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              Diamination of olefins has found broad applications in synthesis of 
pharmaceuticals and catalysts. Vicinal diamination of olefins has been well developed; 
however versatile methods that install higher order 1,n -diamine moieties (e.g., n  = 3− 5) 
are not comprehensively explored. We have developed 1,4-diamination of cyclic dienes 
via diaza-(4+3) cycloadditions of putative diaza-oxyallyl cationic intermediates. This 
novel intermediate was generated by base-mediated dehydrohalogenation of N-chloro 
urea reagents. Various aromatic and non-aromatic cylic dienes underwent successfully 
cycloaddition reaction with diaza-oxyallyl cationic intermediate and provided good to 
excellent yields. Although it was a first example of selective 1,4-diamination of dienes 
using N-chloro urea reagents, this methodology suffers from limited substrate scope and 
poor regioselectivity with mono substituted furans by providing 1:1 ratio of 
regiosisomers. In order to over come the limitations in our previous method, we have 
developed an alternative oxidative 1,4-diamination of conjugated dienes using simple 
urea reagents. The desired putative symmetric diaza-oxyallyl cationic intermediate for the 
oxidative diaza-(4+3) cycloaddition reaction was generated by direct oxidation of urea 
reagents with hypervalent iodine reagent. Oxidative 1,4-diamination is exclusively 
selective for the 1,4-difunctionalization of conjugated dienes due to the required 
Woodward-Hoffmann orbital symmetry rules. This reaction method is compatible with 
various substrates including aromatic, acyclic, and cyclic dienes, and provides 
functionalized unique heterocyclic products. In addition it does not require large excess 
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of diene, which is unusual in (4+3) type of cycloaddition reaction of allyl cations. This 
reaction also demonstrated its compatibility for oxidative intramolecular 1,4-diamination, 
and provides polyheterocyclic molecule.  
 
                  Inspired by the reactivity of daiza-oxyallyl cation for 1,4-daimination we have 
developed an oxidative diaza-(3+2) cycloaddition reaction of simple urea derivatives with 
substituted indoles. This transformation provides rapid access to highly functionalized 
imidazolo- indolines that are represented in large number of designed bioactive 
compounds. This methodology is compatible with wide variety of functional groups and 
provides unique heterocyclic scaffolds. 
 
                Plants defend themselves from pathogens like bacteria, viruses and herbivores 
by using mixture of multiple secondary metabolites as chemical defense. In order to 
understand one of the long-standing and underexplored questions in chemical ecology, 
we have developed a scalable access to enantiopure octopamine and aegeline analogues 
and evaluated the biological assays. These mixtures of products showed synergistic 
activity in defensive mechanism against generalist herbivore (Spodoptera). One of the 
natural product (aegeline) analogue exhibited potency against root growth of Arabodopsis 
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Chapter 1: Introduction 
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                       Nitrogen containing organic structures are widely represented in 
biologically active natural products, pharmaceuticals, materials, and catalysts.1 Among 
them 1,n-Diamines (n = 2 – 5) have gained significant interest from the synthetic 
community due to their applications in catalysis, ligand synthesis and potential to cure 
various diseases.2 Syntheses of vicinal 1,2-diamines from the vincinal deamination of 
alkenes has been well established,2 whereas there are only scarce number of methods 
reported for the 1,4-diamination. The 1,4-diamino motif is extensively found in protease 
inhibitors that include DMP 450 1 (Figure 1.1.1) a cyclic urea is highly potent and orally 
available HIV protease inhibitor, which has been initially developed by DuPont Merck 
Laboratories.3 Ritonavir 2 is a potent antiretroviral medication used in combination with 
other antiretroviral agents and sold under the trade name Norvir to treat the HIV infection 
or AIDS disease.4 Cobicistat 3 (Figure 1.1.1), a structural analog of Ritonavir, has been 
demonstrated to selectively inhibit cytochrome P450 3A (CYP3A) enzyme and helps in 
prolonging the lifetime of a variety of antiretroviral medications, including elvitegravir, 
darunavir and atazanavir.4 1,4-Diaminocyclohexanes 4 (Figure 1.1.1) structural units also 
found in fortimicin antibiotics. Despite the many potential applications, only few 
methods of 1,4-diamination of 1,3-dienes have been reported. Akermark and Bäckvall co-
workers reported in 1979 a method for selective 1,4-daimination by treating the 4-
dimethylamino π-allylic palladium complexes with AgF4 or triphenylphosphine (Scheme 
1.1.1).5b,c,d Although this reaction method is selective for 1,4-diamination is suffers with 
poor yield and very poor substrate scope. In 2012, Muñiz and Lishchynskyi were 
described daimination (1,2 and 1,4) of conjugated alkenes,5a by using Bistosylimide or 
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Bismesylimide as amination source (Scheme 1.1.1). However this methodology is not 
regioselective for 1,4-diamination, it resulted in mixture of 1,2 and 1,4-diamines. 
 
 
Scheme 1.1.1. Reported methods for 1,4-diamination 
 
             The Jeffrey group interest in electrophilic nitrogen species for C-N bond 
formation piqued our interest in development of methods for diamination using aza-
electrophilic intermediates. Cycloaddition reactions are recognized as powerful methods 
for the synthesis of complex natural products including heterocycles.6 Among them, the 
cycloaddition reactions of allyl cations with dienes has been developed as a powerful 
method to construct seven-membered carbocyclic rings.7 Formally this reaction is a [4+3] 
























a) Akermark and Bäckvall co-workers:
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occurs between a diene (4π-electrons) and an allylic cation (2π-electrons), which is an 








              Inspired by the reactions of oxyallyl cations, the Jeffrey group reported the first 
example of the cycloaddition of aza-oxyallyl cationic 6 intermediate (Scheme 1.1.2) with 
cyclic dienes 7, providing a rapid method to prepare seven-membered lactams 8.8,9 The 
intermediate aza-oxyallylic cation was generated by dehydrohalogenation of α-
halohydroxymate 5 by drawing the inspiration from analogous oxyallyl cations, which 
were typically generated via dehydrohalogenation of α-haloketones.7 This initial study 
also demonstrated that the N-alkoxy substituent was necessary to stabilize the 
intermediate and permit the reaction, which was further supported by experimental and 
computational analysis. Armed with the idea of incorporating an alkoxy donor group on 
the nitrogen of the intermediate, we envisioned that access to the analogous diaza-
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One of the primary methods for the generation of both oxyallyl cation and aza-oxyallyl 
cation is base mediated dehydrohalogenation of corresponding α-haloketone and α-
haloamides, therefore we first considered similar dehydrohalogenation reaction of N-
chloro ureas 9 (Scheme 1.1.3) to generate the desired diaza-oxyallyl cationic 10 
intermediate in situ that would then react selectively in an diaza-(4+3) cycloaddition with 
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Figure 1.1.2. Woodward-Hoffman orbital symmetry rules for the Diels-Alder and (4+3)-




                 The required regioselectivity for the 1,4-diamination can be explained by 
Woodward-Hoffman rules for concerted pericyclic reactions first described by R. B. 
Woodward and Ronald Hoffman in 1965 (Figure 1.1.2).11 Analogous to the Diels-Alder 
reaction, the HOMO of the diene has the appropriate symmetry to react with the LUMO 
of the dienophilic diaza-oxyallylic cation to provide selective (4+3)-type cycloaddition 
reaction and would not permit 1,2-diamination through a (3+2) type reaction. Therefore 
according to Woodward-Hoffman rules, it was expected that a (4+3)-cycloaddition of 
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1,4-Difunctionalization (Scheme 1.1.4). Although the (3+2)-cycloaddtion is observed in 
few cases of allyl cations and it is presumably proceed via step vise process. The detailed 
research efforts towards the 1,4-dimination of the cyclic dienes are described in Chapter 
2.   
 
Scheme 1.1.4. Employing orbital symmetry rules to dictate regioselectivity of diamination 
reactions 
 
1.2 Alternative way to generate the diaza-oxyallyl cation 
                    The potential application of a 1,4-diamination reaction for the synthesis of 
pharmaceuticals has inspired us to develop a diaza-{4+3] cycloaddition reaction of 
diazaoxyallylic cations generated by the dehydrohalogenation of N-chloro urea 
reagents.10 Although this methodology is novel and valuable for 1,4-diamiantion of cyclic 
dienes, the intermediate diaza-oxyallyl cation is found to be unreactive with acyclic 
dienes or furans with electron deficient substituents and ultimately provided limited 
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regioisomers due to lack of symmetry in the N-chloro urea reagent or putative diaza-
oxyallyl cationic intermediate. These limitations motivated us to consider an alternative 
way to generate the reactive symmetric diaza-oxyallyl cation from urea derivatives from 
a direct oxidation of a simple urea derivative. The use of hypervalent iodine reagents 
found wide applications in organic synthesis due to their mild oxidizing nature, 
environmentally benign, commercial available and bench top stable.12 Recently these 
reagents have found broad application in generation of N-acylnitrenium ions13 from direct 
oxidation of O-alkyl hydroxamates. The establishment of hypervalent iodide reagents for 
the oxidation of hydroxamates led us to envision the generation of diaza-oxyallylic 
cations through the direct oxidation of urea derivatives. In addition, we expected that 
incorporating an additional stabilizing (O-alkyl) group to another N-terminus of the 
putative diaza-oxyallyl cation could result in further stabilization of the intermediate 13 
(Scheme 1.2.1), which could ultimately lead to the longer lifetime of the intermediate and 
broaden the substrate scope of the reaction. Progress of research towards the generation 
of symmetric diaza-oxyallyl cation 13 for the 1,4-diamination with broader substrate 
scope is described in more detail in Chapter 3. 
 
 




















	   9	  
1.3 Approach toward the 2,3-Diamino Indole via a Dearomative Indole (3+2)-






Figure 1.3.1. Synthetically designed bioactive 2,3-diamino indoles  
 
 
                  The therapeutic potential of 2,3-Diamino indole heterocyclic motifs13,14 have 
inspired the development of methods for their synthesis. Imidazo[4,5-b]indoles 15 
(Figure 1.3.1) and their analogues show significant medicinal properties like antibacterial 
antifungal and anti-inflammatory activities.14 Similarly 6H-indolo[2,3-b]quinoxalines 16 
are important classes of DNA intercalating agents.15 These scaffolds exhibit profound 
bioactivities, which includes anticancer, antiviral, antimutagenic and antiarthritic 
properties. Majority of the reactions reported to construct the 2,3-diamino indole scaffold 
uses multicomponent reactions. Since C2 and C3 heterocyclic fused indoles are 
ubiquitously found in bioactive alkaloids, the dearomative indole cycloaddition reaction 
has recently recognized as an attractive methodology for annulation of indoles. Formal 
(4+2)-cycloaddition of indoles is well established for the synthesis of hydrocarbazoles,16 
where as little is known to (3+2)-cycloaddtion reactions.17 Wu and co-workers have 
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oxyallylic cationic intermediates.18 Inspired by the reactivity of the C2=C3 double bond 
of the indole with oxyallylic cations, we pursued the development of an analogous (3+2) 
heteroannulation of azaoxyallylic cation intermediates and 1,3-disubstituted indoles.19 It 
was our vision that reactions of diaza-oxyallyl cations could react with C2=C3 double 
bond of the indole that would provide a straightforward access to 2,3-diaminoindoles 
(imdizaoloindiolines) (Scheme 1.3.1). Progress toward the development of a diaza-(3+2) 
annulation reaction of diaza-oxyallyl cation intermediates for the construction of 2,3-
diamino indole scaffold using simple urea derivatives is described in Chapter 4.  
 
 
Scheme 1.3.1.  Modular access to imidazoloindolines via dearomative indole (3+2)-cycloaddition 
reaction of diaza-oxyallyl cation 
 
 
1.4 Exploring Ecologically Relevant Biological Activities Through Natural Products 
Synthesis 
 
                 Plants have evolved to defend themselves from herbivores and pathogens (e.g., 
bacteria, virus) by producing mixtures of multiple secondary metabolites that act 
synergistically on multiple targets against a wide variety of enemies.20 The concept of 
synergy in biological activity has potential applications in the design and development of 
new pharmaceuticals and agrochemicals. In targeting multiple active sites, multiple-
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reduce the likelihood of developing resistance. 
 
 
Figure 1.4.1. Octopamine amides and sterols from Manekia obtussa (Piperacae) 
 
              Our collaborative studies in chemical ecology have resulted in the isolation of 
aegeline (octopamine amide), cinnamide, β-sitosterol and stigmasterol (Figure 1.4.1) 
from Manekia obtussa (Piperacae) and these mixtures of phytochemicals have 
demonstrated synergistic activity against generalist (Spodoptera exigua) herbivore, 
significantly reducing survival and pupal mass only when administered as a mixture. 
Many mixtures of plant secondary metabolites are the result of late-stage 
functionalization (e.g., oxidation, reduction, methylation). In order to clarify the effect 
that single structural modifications have on the synergistic activity of the mixture, we 
have developed scalable and enantioselective synthesis of aegeline and its analogs and 
other isolated co-occurring sterols and cinnamide and evaluated the biological activity 
against herbivores. Additionally, we have explored how these unnatural aegeline analogs 
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acyl transferases in cell wall repair and development.  The detail progress of the research 
is described in Chapter 5.  
                  Our scalable synthesis of aegeline provides us access to octopamine, p-
hydroxyethanolamine is an endogenous biogenic amine was first discovered in the 
salivary glands of octopus vulgaris. Octopamine is found in both vertebrate and 
invertebrate nervous systems; however, in invertebrates it is present comparatively in 
high concentrations in central, peripheral nervous systems and several other insect 
tissues. In insects’ nervous systems, octopamine serves as a neurotransmitter, 
neuromodulator, and neurohormone and plays an important role for influencing multiple 
physiological events, including immune response and memory and cognition. As a part of 
our ongoing research efforts in understanding the role of secondary metabolites in plant-
insect interactions, we discovered that octopamine is produced in the floral nectar of 
citrus plants.  This discovery has important implications in behaviors of insects and other 
vertebrate pollinators. In order to understand the ecologically relevant biological 
activities of the octopamine, we developed a scalable and enantioselective synthesis of 
octopamine (R or S). The detail research for the synthesis of octopamine and the current 
studies are described in Chapter 5. 
 
1.5 References 
1. Mercado-Marin, E. V.; Garcia-Reynaga, P.; Romminger, S.; Pimenta, E. F.; 
Romney, D. K.; Lodewyk, M. W.; Williams, D. E.; Andersen, R. J.; Miller, S. J.; 
Tantillo, D. J.; Berlinck, R. G. S.; Sarpong, R. Nature  2014, 509, 318. 
2. Cardona, F.; Goti, A. Nat. Chem. 2009, 1, 269. 
	   13	  
3. Lam, P. Y. S.; Jadhav, P. K.; Eyermann, C. J.; Hodge, C. N.; Ru, Y.; Bachelor, L. 
T.; Meek, J. L.; Otto, M. J.; Rayner, M. M.; Wong, Y. N.; Chang, C.-H.; Weber, 
P. C.; Jackson, D. A.; Sharpe, T. R.; Erickson-Vittanen, S. Science 1994, 263, 
380. (b) De Lucca, G. V.; Lam, P. Y. S. Drugs Future 1998, 23, 987. 
4. Sherman, E. M.; Worley, M. V.; Unger, N. R.; Gauthier, T. P.; Schafer, J. J. Clin. 
Ther. 2015, 37 , 1876. 
5.  a) Lishchynskyi, A.; Mu~niz, K. New J. Chem. 2012, 18, 2212. (b) Bäckvall, J. 
E. Acc. Chem. Res. 1983, 16, 335. (c) Bäckvall, J.-E.; Nyström, J.–E. J. Chem. 
Soc., Chem. Commun. 1981, 59. (d) Akermark, B.; Bäckvall, J.-E.; Löwenborg, 
A.; Zetterberg, K. J. Organomet. Chem. 1979, 166, 33. 
6. (a) Wang, Y.; Yu, Z.-X. Acc. Chem. Res. 2015, 48, 2288. (b) Sears, J. E.; Boger, 
D. L. Acc. Chem. Res. 2015, 48, 653. (c) Ylijoki, K. E. O.; Stryker, J. M. Chem. 
Rev. 2013, 113, 2244. (d) Harmata, M.; Ghosh, S.K.; Hong, X.; Wacharasindhu, 
S.; Kirchhoefer, P. J. Am. Chem. Soc. 2003, 125, 2058.  
7.  (a) Harmata, M. Chem. Commun. 2010, 8904. (b) Harmata, M. Chem. Commun. 
2010, 8886. (c) Huan, J.; Hsung, R.P. Chemtracts 2005, 18, 207. (d) Harmata, M. 
Adv. Synth. Catal. 2006, 2297. (e) Harmata, M. Acc. Chem. Res. 2001, 34, 595. 
8. Jeffrey, C. S.; Barnes, K. L.; Eickhoff, J. A.; Carson, C. R. J. Am. Chem. Soc. 
2011, 133, 7688. 
9. (a) Lengyel, I.; Sheehan, J.C. Angew. Chem. Int. Ed. 1968, 7, 25. (b) Stang, P.J.; 
Anderson, G.H. Gazz. Chim. Itl. 1995, 125, 329. 
10. Jeffrey, C. S.; Anumandla, D.; Carson, C. R. Org. Lett. 2012, 14, 5764. 
11. Hoffman, R.; Woodward, R.B. J. Am. Chem. Soc. 1965, 87, 2046. 
	   14	  
12. (a) Charpentier, J.; Fruh, N.; Togni, A. Chem. Rev. 2015, 115, 650. (b) Zhdankin, 
V. V. J. Org. Chem. 2011, 76, 1185 (c) Zhdankin, V. V. ARKIVOC (Gainesville, 
FL, U. S.) 2009,  1, 1-62. 
13. (a) Wardrop, D. J.; Bowen, E. G. Synthetic Applications of Nitrenium Ions. In 
Nitrenes and Nitrenium Ions; Falvey, D. E., Gudmundsdottir, A. D., Eds.; Wiley: 
Weinhiem, 2013; pp 347−449. (b) Kikugawa, Y. Heterocycles 2009, 78, 571 and 
references cited therein. 
14. (a) Darbu, S.; Kumar, N.; Munirajan, S. Asian J. Chem. 2007, 19, 4124. (b) 
Darbu, S.; Kumar, N.; Munirajan, S. Indian J. Heterocyl. Chem. 2005, 15, 195. 
(c) Darbu, S.; Kumar, N.; Munirajan, S. Indian J. Heterocyl. Chem. 2005, 15, 91. 
(d) Sahu, S. K.; Mishra, S. K.; Pattanayak, S. P.; Mohanta, R. K.; Panda, C. S. J. 
Teach. Res. Chem. 2004, 11, 95. (e) Velezheva, V. S.; Tomchin, A. B.; Mel'man, 
A. I.; Marysheva, V. V., Russ. J. Org. Chem. 1998, 34, 570. 
15. (a) Moorthy, N.; Manivannan, E.; Karthikeyan, C.; Trivedi, P. Mini Rev. Med. 
Chem. 2013, 13, 1415. (b) Homman, M.; Kingi, N.; Bergman, J.; Engqvist, R. 
Preparation of antiviral indolo[2,3-b]quinoxalines. W02014140321A1, 2014. (c) 
Wilhemsson, L. M.; Kingi, N.; Bergman, J. J. Med. Chem. 2008, 51, 7744. 
16. (a) Kawano, M.; Kiuchi, T.; Negishi, S.; Tanaka, H.; Hoshikawa, T.; Matsuo, J.; 
Ishibashi, H. Angew. Chem., Int. Ed. 2013, 52, 906. (b) Cai, Q.; You, S. L. Org. 
Lett. 2012, 14, 3040. (c) Zhang, G.; Huang, X.; Li, G.; Zhang, L. J. Am. Chem. 
Soc. 2008, 130, 1814. (d) Biolatto, B.; Kneeteman, M.; Paredes, E.; Mancini, P. 
M. E. J. Org. Chem. 2001, 66, 3906. (e) Hsieh, M.; Rao, P. D.; Liao, C. C. Chem. 
Comm 1999, 1441. 
	   15	  
17. (a) Xiong, H.; Xu, H.; Liao, S.; Xie, Z.; Tang, Y. J. Am. Chem. Soc. 2013, 135, 
7851. (b) Lian, Y.; Davies, H. M. L. J. Am. Chem. Soc. 2010, 132, 440. (c) 
Barluenga, J.; Tudela, E.; Ballesteros, A.; Tomas, M. J. Am. Chem. Soc. 2009, 
131, 2096. (d) Bajtos, B.; Yu, M.; Zhao, H.; Pagenkopf, B. L. J. Am. Chem. Soc. 
2007, 129, 9631. (e) England, D. B.; Kuss, T. D. O.; Keddy, R. G.; Kerr, M. A. J. 
Org. Chem. 2001, 66, 4704. 
18. (a) Wu, J., Synthesis. 2015, 47, 22. (b) Li, H.; Hughes, R. P.; Wu, J. J. Am. Chem. 
Soc. 2014, 136, 6288. 
19. Acharya, A.; Anumandla, D.; Jeffrey, C. S. J. Am. Chem. Soc. 2015, 137, 14858 . 
20. (a) Dyer, L. A.; Richards, L. A.; Short, S. A.; Dodson, C. D. PLoS One 2013, 8, 
e62528. (b) Challis, G. L.; Hopwood, D. A. Proc. Natl. Acad. Sci. U. S. A. 2003, 
100, 14555. (c) Firn, R. D.; Jones, C. G. Nat. Prod. Rep. 2003, 20, 382. (d) Jones, 











	   16	  
Reproduced in part with permission from Jeffrey, C. S.; Anumandla, D.; Carson, C. R. 
Org. Lett. 2012, 14, 5764. Copyright 2012 American Chemical Society. 
 
 




                Vicinal and higher order 1,n (n = 3–5) diamines are structural motifs prevalent 
in many biological active natural products, pharmaceuticals, and materials.1-3 Among 
them, DMP-4501 1 and Ritonavir 2 are potent anti-HIV molecules.3 Cobicistat2 3 
structurally analogues to the antiviral drug Ritonavir3c 2 aid in prolonging certain 
antiretroviral medications (elvitegravir, darunavir and atazanavir) by inhibiting their 
metabolism. Vicinal 1,2-diamination of dienes and alkenes are the most studied method 
among the methods for the diamination of alkenes.4 Despite of their biological 
importance to cure various diseases, syntheses of diamine molecules are complicated and 
methods to install selective higher order diamino motifs (e.g. 1,4) from simple starting 
materials have not been well developed.5 The most widely used methods for 1,4-
diamination are hetero Diels–Alder reactions of diazocarboxylates and triazine6 however, 
the utility has been limited due to competitive “ene” side reactions and also the explosive 
hazards of the diazidocarboxylates.  
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                 Cycloaddition reactions are established as powerful reaction methods not only 
due to a high economy, but also because of their high stereoselectively, which have been 
widely applied to the synthesis of various structurally complex molecules. Among them, 
(4+3) cycloaddition reactions of dienes and allylic cations have brought significant 
interest from the synthetic community for the preparation of seven-membered 
carbocycles.7 The Jeffrey’s group interests in the generation and exploration of the 
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bonds, has recently led to the development of an aza-(4+3) cycloaddition of a putative 
aza-oxyallylcation intermediate with cyclic dienes.8 
 
2.2 Generation and Trapping of Diaza-oxyallyl Cationic Intermediate  
 
 
Scheme 2.2.1. Hetero-(4+3) cycloaddition of aza and diaza-allyl cations with dienes. 
 
              As part of our ongoing research interest in the reactivity of electrophilic nitrogen 
species we envisioned that a hetero-(4+3) type cycloaddition of a putative diaza-oxyallyl 
cation could serve for a chemoselective 1,4-diamination providing seven-membered 
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generation of an aza-oxyallylcationic 6 intermediate by dehydrohalogenation of α-
halohydroximates8 5 and the corresponding intermediate was successfully trapped with 
cyclic dienes, which ultimately provided 7-membered nitrogen containing heterocycles 8 
(Scheme 2.2.1). Therefore, in the similar fashion dehydrohalogenation of N-chloro ureas 
9 with an appropriate base could generate diaza-allyl cationic intermediate 10, which 
could then react with a diene to provide, 7-memebred cyclic urea 11, which could serve 
as a precursor to 1,4-diamines. To test our hypothesis, we prepared N, N'-dibenzyl, 
dialkyl, and diaryl ureas and subjected them to N-chlorination. Our initial attempts for 
selective mono N-chlorination with tert-butyl hypochlorite failed due to the formation of 
a complex mixture of products. However, we found that selective N-chlorination of N-
alkoxy ureas on the N-alkoxy nitrogen was achieved successfully with tert-butyl 
hypochlorite in dichloromethane.9  
 



















R1 = Me (25a), Et (25b) or Bn (25c)
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Using similar reaction conditions, N-chlorination of N-ethoxy, N-methoxy and N-
benzyloxy benzyl ureas 25 were provided their corresponding N-chloro ureas 26 in good 
yield (26a, 82%, 26b 79%, 26c 75%) after washing with hexane (Scheme 2.2.2). After 
preparation of the mono N-chloro urea 26 we were in place to investigate the proposed 
cycloaddition reaction with furan. Indeed, treatment of N-chloro urea 26 with furan 27 
under Föhlisch conditions (CF3CH2OH, Et3N),10 provided the desired cycloadduct 29 in 
18% yield (Scheme 2.2.1). The major byproducts from this reaction conditions are 
solvolysis 30 and urea 28. 
 
2.3 Optimization and Exploring the Substrate Scope of the Daiaza-(4+3) 
Cycloaddtion Reaction  
                    Various N-chloro ureas 26 were found to undergo diaza-(4+3) cyloaddition 
with furan 27 and with other dienes. We discovered that the nature of the substituents (R1 
= Bn, Et, Me) on the N-chlorourea at the N-alkoxy terminus had a very little effect on the 
yield of the reaction. Although the yield was not significantly affected by the nature of 
the R1, it was our findings that the ethyl and benzyl substituted substitute hydroxy ureas 
were easier to handle due to their solubility and chromatographic characteristics. 
Changing the base form Et3N to the more basic sodium salt of 2,2,3,3-
tetrafluororpropanol (TFP/TFP-Na) was found to give the highest yield (74%) of the 
cycloadduct 29 with negligible amounts of solvolysis product 30.11 The significant 
improvement on yield of the cycloadduct was achieved only when we changed the rate of 
addition of N-chloro urea 26 in CH3CN over a period of 3 hours to the mixture of base 
and diene at 0 °C. The order and rate of addition were found to dramatically affect the 
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yield of the cycloaddition of electron-rich dienes. For example, the yield of the 
cycloadduct of 2,5-dimethyl furan improved from 35% to 65% yield when the N-
chlorourea was added over 3 h.  




a Conditions: N-Chlorourea 31 in CH3CN was added to a solution of the diene and TFP-Na (2.0 
equiv.) in TFP (0.25 M). b Isolated yield of the cycloadduct 32a. 
 
        
           It is common that, the (4+3) reactions are run with an excess of the diene (>10 
equiv.)7 concentration however, we were surprised to observe similar yields in optimized 
conditions even though the diene concentration was altered from 1.1, 5.0 to 25 
equivalents (Table 2.3.1). It revealed that this reaction method was not very sensitive to 
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a Conditions: N-Chlorourea 31 in CH3CN was added to a solution of the diene [5 equiv (condition 
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          With optimized reaction conditions in our hand, next we explored the scope of the 
reaction with various dienes. Unsubstituted dienes, cyclopentadiene, N-Boc pyrrole, 
methy pyrrole carboxylate and furan (Table 2.3.2, 32a, 32b, 32c, 32d) all were found to 
undergo the cyloaddtion in similar fashion and provided excellent yields of the desired 
cycloadducts. Substituted, symmetrical furans like 2,5-disubstuted and 3,4-disubstituted 
furans (Table 2.3.2, 32e, 32f) furnished good to excellent yields. However, the dienes 
with electron deficient substituent, the 2-carboethoxy furan, as well as acyclic dienes like 
isoprene and 2,3-dimethyl-1,4-butdiene did not undergo cycloaddition with diaza-allylic 
cations, but instead, provided only the solvolysis products.12 The unreacted dienes were 
recollected after workup and subsequent column chromatography. 6,6-Dimethylfulvene, 
and [2.2.2]-spiro-heptadiene (Table 2.3.2, 32g, 32h) were observed to undergo 
cycloaddition by resulting both in good to excellent yields. We observed fair yield with 
1,3-cyclohexadine (Table 2.3.2, 32i). Fulvenes contain both a polarized reactive alkene 
and a cyclic diene system.  The observation of exclusive [4+3] type regioselectivity is 
highly suggestive of a process where the selectivity is dictated by orbital symmetry rules. 
Mono-substituted dienes provided close to 1:1 mixture of regioisomeric products without 
the hydroxamate substituents effect (Table 2.3.3).13 This observation is due to the 
presence of asymmetry in the N-chloro urea 31 susbrate or in the diza-oxyallyl cationic 
intermediate. The regiosiomeric ratio was determined by 1H NMR analysis of the crude 
products. Using symmetric dibenzyloxy or methoxy ureas would resolve this 
regiosiomeric issue, however selective mono-chlorination of these ureas was not 
successful and produced mixtures of undesired (dichlorinated) products.  Presumably, the 
dicholorinated products were extremely unstable and initiated radical decomposition of 
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the desired mono-chloro products. Despite the formation of two regioisomers with 
monosubstituted furans, the combined yields of both regioisomers were found to be 
excellent with 2-methyl furan and 3-bromofuran, whereas 2-hydoxymethylfuran (Table 
2.3.3, entries 1-3) resulted in good yields. Over all we found that electron-rich dienes 
furnished good yields under these cycloaddition conditions.  
 
Table 2.3.3. Scope of the Diaza-(4+3) Cycloaddition of N-chloro Urea 31 with 




a Conditions: N-Chlorourea in CH3CN was added to a solution of the diene [5 equiv (condition 
A)] and TFP-Na (2.0 equiv) in TFP (0.25 M). b Isolated yield of both regioisomers of the 
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2.4 Proposed Mechanism for the Generation of Diaza-oxyallyl Cationic 
Intermediates 
                   Choice of a base, sodium alkoxide of 2,2,3,3-tetrafluororpropanol (TFP/TFP-
Na) over Et3N was found to improve the yield (74%) of the cycloadduct with furan. This 
result may be due to the fact that Et3N+H (pKa = 9.8) is about one thousand times more 
acidic than 2,2,3,3-tetrafluoropropanol (TFP, pKa = 12.7). It was our hypothesis that 
increasing the strength of the base provide higher concentration of amidate anion 35 and 
further loss of chloride ion from amidate anion 35 generates a higher concentration of 
desired diaza-oxyallyl cationic intermediate 37 and ultimately lead to the high yield of 
the cycloadduct 29. Another important observation was that the rate of addition of N-
chloro urea substrate in CH3CN improved the yield of the cycloadduct significantly and 
minimized by-products 28 and 30. This important result is likely due to the rate of 
addition of substrate is equal to consumption of generated diaza-allylic cation. These 
findings led us to explore more about the mechanistic pathway of the reaction. To explore 
the mechanism of this reaction, we subjected the N-chloro urea substrate 26 to various 
control experiments and made the following observations: 1) Treatment with 2,2,3,3-
tetrafluoropropanol (TFP) delivered exclusively the solvolysis product 30. 2) Exposing 
the substrate to furan provided the urea 28 quantitatively along with negligible amount of 
cycloadduct 29, and finally 3) with mixture of furan, TFP and Et3N delivered products 
28, 29 and 30. Based on these observations we rationalize that majority of cycloadduct is 
being formed by a pathway where by deprotonation provides the amidate anion, which 
undergoes loss of chloride to form the aza-allylic cation.  Additionally, we rationalized 
that the formation of the undesired products 28 and 30 (Scheme 2.4.1) were predominantly 
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the result of premature loss of chloride or chlorination of the furan by the neutral N-
chlorourea.  Use of stronger base was used in the reaction (TFP-Na vs. Et3N) led to a 
higher equilibrium concentration of the amidate anion 35 resulting in a preference for 
cycloadduct 29.  Slow addition of the N-chlorourea 26 minimized its concentration 
relative to the amidate anion 35, thereby minimizing the relative rate of formation of the 
undesired products.	   Further detailed mechanistic investigations of the proposed 
mechanistic pathways are ongoing. 
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2.5 Applications of Substrates Generated from Diaza-(4+3) Cycloaddion Reaction 
 
Scheme 2.5.1. Selective transformations of the [3.2.2] diazabicylcoheptane. 
 
                  1,4-diamino motifs have found in a variety of biologically active molecules1-3. 
Therefore the substrates derived from our diaza-(4+3) cycloaddition methods can serve 
for the synthesis of a wide variety of building blocks for pharmaceuticals and natural 
products. In order to show the synthetic utilities of cyloadducts derived from this 
methodology, we selected the [3.2.2] diaza-bicyclononene 32i as a model compound and 
exposed this bicyclic urea to various reaction conditions (Scheme 2.5.1). Selective alkene 
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methanol at room temperature to deliver the product 39 without cleavage of either of the 
benzyl groups or N-O bond. Subjecting 32i to more vigorous hydrogenation conditions 
with Pd/BaSO4, cleaved both the O-benzyl and N-benzyl groups to provide the 
hydroxamic acid 40 in good yield. Using Mo(CO)6, the N-O bond of substrate 32i 
selectively reduced to the secondary amide 41 in presence of N-benzyl group and the 
alkene. Diastereoselective oxidation of the alkene from the convex-face of diaza-[3.2.2] 
bicycloadduct 32i could be achieved with OsO4 to provide vicinal syn-1,2-diol 42 and 
with dimethyldioxirane (DMDO)15 to deliver an epoxide 43. Reductive ring opening with 
LiAlH4 led to N-methyl diaimine 44 in good yield as the major regioisomeric product (ca. 
3:1 r.r) and the regioisomeric ratio of the reduced products were determined by 1H NMR 
analysis of crude mixture. 
   
2.6 Experimental 
All reactions were carried out under an atmosphere of nitrogen in oven-dried glassware 
with magnetic stirring, unless otherwise specified. Dichloromethane was purified by 
passage through a bed of activated alumina. Cyclopentadiene was distilled from 
dicyclopentadiene immediately prior to use.  All other reagents and solvents were 
purchased from Sigma-Aldrich Chemical Company and used without any further 
purification.  2,2,3,3-tetrafluoropropan-1-ol was purchased from SynQuest and used 
without further purification.  TLC information was recorded on Silicycle glass 60 F254 
plates and developed by staining with KMNO4 or ceric ammonium molybdate. 
Purification of reaction products was carried out by flash chromatography using Silicycle 
Siliaflash® P60 (230-400 mesh). 1H-NMR spectra were measured on Varian 400 (400 
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MHz), Varian MR400 (400 MHz), or Varian 500 (500 MHz) spectrometers and are 
reported in ppm (s=singlet, d=doublet, t=triplet, q=quartet, m=multiplet, br=broad; 
integration; coupling constant(s) in Hz), using TMS as an internal standard (TMS at 0.00 
ppm) in CDCl3 or the solvent peak (2.54) in (CD3)2SO. 1H-NMR and 13C-NMR spectra 
were recorded on V400 or V500 spectrometer and reported in ppm using solvent as an 
internal standard (CDCl3 at 77.16 ppm) or (CD3CN at 118.26 ppm). Infrared (IR) spectra 
were recorded on a Nicolet 6700 FT-IR with a diamond ATR and data are reported as cm-
1 (br = broad, s = strong). High-resolution mass spectra were obtained using an Agilent 
6230 TOF LC/MS with an (atmospheric pressure photo-ionization (APPI) or electrospray 
(ESI) source with purine and HP-0921 as an internal calibrants.  
 
General procedure A: Preparation of 1-Propanol, 2,2,3,3-tetrafluoro-, sodium salt  
(NaTFP) 
To a solution of 2,2,3,3-tetrafluoropropanol (TFP) (86.95 ml, 1M), was added freshly cut 
pieces of sodium (2.0 gm) under nitrogen at room temperature over a period of 4 hours. 
The resulting mixture was stirred for additional 4 hours and the reaction was concentrated 
under vacuum using a rotary evaporator. The NaTFP product was flushed with nitrogen 
before removing the flask from rotary evaporator and the residual solvent was removed 
under vacuum for 2 days to obtain 13.0 g of milky white solid. The NaTFP product was 
stored under nitrogen in the refrigerator for several weeks. 
________________________________________________________________________  
General procedure B: synthesis of N-chloro urea (N-methoxy, N-ethoxy, and N- benzyl, 
benzyloxy): 26 or 31  
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t-butyl hypochlorite (2.0 equiv) was added drop wise at 0 °C to a solution of a urea (1.0 
equiv) in dichloromethane (0.2 M) at 0 °C, and the reaction mixture was stirred at 0 °C 
for 10 minutes in the dark and nitrogen atmosphere until complete consumption of urea 
was confirmed by TLC (3:2, hexanes: ethyl acetate). The solvents were removed from the 
reaction mixture by using rotary vapor and washed with hexane to provide the colorless 
crystalline N-chloro urea 2 as a solid. 
_______________________________________________________________________ 
General procedure C: For the cycloaddition reaction of furan or other cyclic dienes 
in 2,2,3,3-Tetrtafluoro-1-propanol 
 
To a solution of CHF2CF2CH2OH (0.25 M with respect to diene) and CHF2CF2CH2ONa 
(2.0 equiv) was added corresponding cyclic dienes (A = 5.0 equiv or B = 1.1 equiv) 
dropwise at 0 °C. A solution of the N-chloro urea 2 (1.0 equiv) in anhydrous CH3CN (4.0 
mL/0.344 mmol of N-chloro urea) was added dropwise at 0 °C over a period of 3.0 hours 
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of N-chloro urea was observed by TLC (3:2, hexanes: ethyl acetate). The volatiles were 
removed under reduced pressure and the residue was partitioned between ethyl acetate 
(100 mL) and water (50 mL) and extracted with ethyl acetate (2 x 100 mL). The 
combined organic phase was dried over anhydrous MgSO4 or Na2SO4 and concentrated 
under reduced pressure. The crude product was purified via flash column 
chromatography (4:1 to 3:2, hexanes: ethyl acetate) to provide the cycloadducts as oils 
(58-95% yield). 
Note #1: The product of Furfuryl alcohol was purified via flash column chromatography 






Prepared in (75%) yield via procedure reported in Tetrahedron Letters 46 (2005) 8841–
8843. 
Rf = 0.38 (1:1, hexanes: ethyl acetate); mp = 86.0-87.7 °C; 1H-NMR (400 MHz, CDCl3): 
δ 7.35 – 7.26 (m, 8H), 7.20 – 7.18 (m, 2H), 7.04 (brs, 1H), 5.89 (brs, 1H), 4.78 (s, 2H), 
and 4.39 (d, J = 6.0 Hz, 2H); 13C-NMR (101 MHz, CDCl3): δ 160.0, 138.4, 135.4, 129.2, 
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2931, 2869, 1950, 1656, 1605, 1584, 1543, 1493, 1452, 1430, 1369, 1323, 1300, 1210, 
1148, 1073, 1024, 1002, 968, 938, 904 cm-1; HR-ESIMS calculated for C15H17N2O2 








Prepared in (84%) yield via general procedure B. Rf = 0.43 (4:1, hexanes: ethyl acetate); 
mp = 113.2-114.9 °C; 1H-NMR (400 MHz, CDCl3): δ 7.37 – 7.27 (m, 8H), 7.13 (dd, J = 
7.6, 2.0 Hz, 2H), 6.25 (brs, 1H), 4.98 (s, 2H), and 4.40 (d, J = 5.9 Hz, 2H); 13C-NMR 
(126 MHz, CDCl3): δ 159.6, 137.1, 133.9, 129.7, 129.3, 128.8, 128.8, 127.8, 127.5, 77.0, 
and 45.2; IR (film) 3388, 3061, 2946, 1957, 1707, 1584, 1494, 1453, 1425, 1359, 1303, 
1261, 1206, 1108, 1084, 1048, 1026, 973, 934, 913 cm-1; HR-ESIMS calculated for 





















Prepared in (A = 93 % or B = 87 %) yield (A = 102 mg, 0.31 mmol or B = 95.7 mg, 0.29 
mmol) from the reaction of N-chloro-N-(phenylmethoxy)-N'-(phenylmethyl)urea 31 (A or 
B = 100 mg, 34 mmol) with furan (A = 0.125 ml, 1.71 mmol or B = 0.027 ml, 0.37 
mmol) via general procedure C. Rf = 0.60 (3:2, hexanes: ethyl acetate); 1H-NMR (400 
MHz, CDCl3): δ 7.47 – 7.44 (m, 2H), 7.40 - 7.25 (m, 8H), 6.13 (dd, J = 5.8, 1.0 Hz, 1H), 
6.04 (dd, J = 5.8, 1.2 Hz, 1H), 5.33 (d, J = 1.1 Hz, 1H), 5.28 (d, J = 1.1 Hz, 1H), 5.05 (d, 
J = 11.2Hz, 1H), 5.01 (d, J = 11.2Hz, 1H), 4.66 (d, J = 15.3 Hz, 1H), and 4.50 (d, J = 
15.3 Hz, 1H); 13C-NMR (101 MHz, CDCl3): δ 156.4, 137.3, 136.2, 134.0, 130.9, 129.8, 
128.8, 128.6, 128.5, 128.2, 127.8, 93.2, 89.0, 79.1 and 47.8; IR (film) 3030, 2928, 1677, 
1495, 1453, 1438, 1408, 1357, 1333, 1232, 1145, 1098, 1074, 1000, 945 cm-1; HR-
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(±)-(5R, 1S) 2-(phenylmethoxy)-4-(phenylmethyl)-2,4-diazabicyclo[3.2.1]oct-6-en-3-
one (32b)  
 
 
Prepared in (A = 92 % or B = 95 %) yield (A = 508 mg, 1.58 mmol or B = 105 mg, 0.33 
mmol) from the reaction of N-chloro-N-(phenylmethoxy)-N'-(phenylmethyl)urea 31 (A = 
500 mg, 1.72 mmol or B = 100 mg, 0.34 mm) with cyclopentadiene (A = 0.708 ml, 1.71 
mmol or B = 0.031 ml, 0.37 mmol) via general procedure C. Rf = 0.60 (3:2, hexanes: 
ethyl acetate); 1H-NMR (400 MHz, CDCl3): δ 7.48 – 7.45 (m, 2H), 7.36 - 7.22 (m, 8H), 
6.14 (dd, J = 5.7, 2.2 Hz, 1H), 5.91 (dd, J = 5.7, 2.4 Hz, 1H), 5.06(d, J = 10.9 Hz, 1H), 
4.96(d, J = 10.9 Hz, 1H), 4.57 (d, J = 14.9 Hz, 1H), 4.50 (d, J = 14.9 Hz, 1H), 4.05 (ddd, 
J = 4.1, 1.6, 0.8 Hz, 1H), 3.74 (ddt, 3.9, 2.5, 1.3, 1H), 1.98 (dt, J = 10.8, 0.8 Hz, 1H), and 
1.74 (dt, J = 10.8, 4.1 Hz, 1H); 13C-NMR (101 MHz, CDCl3): δ 158.4, 138.4, 136.6, 
136.5, 134.2, 129.6, 128.5, 128.4, 128.3, 128.3, 127.4, 78.4, 64.9, 59.1, 50.1, and 39.7; IR 
(film) 3061, 3029, 2950, 1664, 1494, 1438, 1409, 1355, 1276, 1247, 1205, 1186, 1156, 
1070, 1027, 1000, 965, 927 cm-1; HR-ESIMS calculated for C20H21N2O2 (M+H)+ 
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(±)-(5R, 1S) tert-Butyl-3-oxo-2-(phenylmethoxy)-4-(phenylmethyl)-2,4,8-




Prepared in (A = 82 %) yield (A = 119 mg, 0.28 mmol) from the reaction of N-chloro-N-
(phenylmethoxy)-N'-(phenylmethyl)urea 31 (A = 100 mg, 0.34 mm) with tert-Butyl 1-
pyrrolecarboxylate  (A = 0.287 ml, 1.71 mmol) via general procedure C. Rf = 0.68 (3:2, 
hexanes: ethyl acetate); 1H-NMR at 90 °C (500 MHz, (CD3)2SO): δ 7.46 (dd, J = 8.0, 1.8 
Hz, 2H), 7.39 – 7.32 (m, 7H), 7.29 – 7.26 (m, 1H), 6.46 (dd, J = 5.9, 2.2 Hz, 1H), 6.38 
(dd, J = 6.0, 2.2 Hz, 1H), 5.63 (d, J = 2.3,  Hz, 1H), 5.33 (d, J = 2.4, Hz, 1H), 4.97 (d, J = 
10.8 Hz, 1H), 4.94 (d, J = 10.8 Hz, 1H), 4.51 (d, J = 15.4 Hz, 1H) 4.46 (d, J = 15.1 Hz, 
1H), and 1.40 (s, 9H); 13C-NMR at 90 °C (126 MHz, (CD3)2SO): δ 157.0, 151.5, 138.8, 
136.6, 135.8, 132.5, 129.3, 128.7, 128.6, 128.6, 128.5, 127.6, 81.5, 78.2, 75.4, 72.6, 48.9 
and 28.2; IR (film) 2975, 2930, 1716, 1680, 1495, 1454, 1437, 1365, 1331, 1286, 1235, 
1164, 1113, 1070, 1001, 930 cm-1; HR-ESIMS calculated for C24H28N3O4 (M+H)+ 
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(±)-(5R, 1S) methyl-3-oxo-2-(phenylmethoxy)-4-(phenylmethyl)-2,4,8-




Prepared in (A = 90 %) yield (A = 117 mg, 0.30 mmol) from the reaction of N-chloro-N-
(phenylmethoxy)-N'-(phenylmethyl)urea 31 (A = 100 mg, 0.34 mm) with methyl 1-
pyrrolecarboxylate  (A = 0.193 ml, 1.71 mmol) via general procedure C. Rf = 0.50 (3:2, 
hexanes: ethyl acetate); 1H-NMR at 90 °C (500 MHz, (CD3)2SO): δ 7.46 (dd, J = 8.0, 1.7 
Hz, 2H), 7.40 – 7.32 (m, 7H), 7.31 - 7.27 (m, 1H), 6.47 (dd, J = 6.0, 2.1 Hz, 1H), 6.37 
(dd, J = 6.0, 2.3 Hz, 1H), 5.62 (d, J = 2.0 Hz, 1H), 5.40 (dd, J = 2.1, 0.9 Hz 1H), 4.96 (d, 
J = 10.9 Hz, 1H), 4.92 (d, J = 10.8, 1H), 4.49 (s, 2H), and 3.62 (s, 3H); 13C-NMR at 90 
°C (126 MHz, (CD3)2SO): δ 156.9, 152.8, 138.6, 136.6, 135.7, 132.4, 129.4, 128.7, 
128.6, 128.6, 127.6, 78.3, 75.5, 72.5, 53.2, 53.2 and 48.8; IR (film) 3030, 2953, 1722, 
1679, 1585, 1495, 1440, 1403, 1366, 1281, 1233, 1115, 1070, 1028, 1000, 971, 908 cm-1; 
















Prepared in (A = 73 %, B = 75 %) yield (A = 88 mg, 0.25 mmol, B = 90 mg, 0.26 mmol) 
from the reaction of N-chloro-N-(phenylmethoxy)-N'-(phenylmethyl)urea 31 (A or B = 
100 mg, 0.34 mm) with 2,5-Dimethylfuran (A = 0.183 ml, 1.71 mmol or B = 0.040 ml, 
0.37 mmol) via general procedure C. Rf = 0.73 (3:2, hexanes: ethyl acetate); 1H-NMR 
(400 MHz, CDCl3): δ 7.49 – 7.46 (m, 2H), 7.39 - 7.21 (m, 8H), 6.13 (d, J = 5.6 Hz, 1H), 
5.83 (d, J = 5.6 Hz, 1H), 5.27(d, J = 9.9 Hz, 1H), 4.96(d, J = 9.9 Hz, 1H), 4.90 (d, J = 
16.0 Hz, 1H), 4.45 (d, J = 16.0 Hz, 1H), 1.65 (s, 3H), and 1.59 (s, 3H); 13C-NMR (101 
MHz, CDCl3): δ 159.0, 139.1, 137.1, 135.6, 133.5, 129.7, 128.5, 128.5, 128.4, 127.7, 
127.2, 99.2, 96.7, 80.3, 45.7, 20.0, and 19.5; IR (film) 3103, 3021, 2879, 1674, 1600, 
1493, 1474, 1453, 1394, 1358, 1292, 1224, 1166, 1118, 1078, 1035, 995 cm-1; HR-
















Prepared in (A = 76 %) yield (A = 99 mg, 0.26 mmol) from the reaction of N-chloro-N-
(phenylmethoxy)-N'-(phenylmethyl)urea 31 (A = 100 mg, 0.34 mm) with 3,4-
Bis(hydroxymethyl)furan (A = 0.176 ml, 1.71 mmol) via general procedure C. Rf = 0.23 
(1:4, hexanes: ethyl acetate); 1H-NMR (400 MHz, CDCl3): δ 7.46 – 7.43 (m, 2H), 7.41 - 
7.26 (m, 8H), 5.32 (s, 1H), 5.27 (s, 1H), 5.07(d, J = 11.2 Hz, 1H), 5.01 (d, J = 11.2 Hz, 
1H), 4.77 (d, J = 15.5 Hz, 1H), 4.39 (d, J = 15.4 Hz, 1H), 4.14 (d, J = 14.8 Hz, 1H), 4.07 
(d, J = 14.6 Hz, 1H), 4.05 (d, J = 14.6 Hz, 1H), 3.97 (d, J = 14.6 Hz, 1H), 3.13 (brs, 1H), 
and 2.94 (brs, 1H); 13C-NMR (101 MHz, CDCl3): δ 156.8, 142.4, 138.8, 136.7, 135.9, 
129.6, 128.8, 128.8, 128.6, 128.0, 127.9, 94.6, 90.7, 79.2, 56.5, 55.6, and 48.0; IR (film) 
3372 (br) 3031, 2926, 1658, 1495, 1444, 1416, 1357, 1243, 1152, 1075, 1000, cm-1; HR-
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(±)-(5R, 1S) 2-(phenylmethoxy)-4-(phenylmethyl)-2,4-diaza-spiro[bicyclo[3.2.1]oct-6-
en-8,1'-cyclopropan]-3-one (32g)  
 
 
Prepared in (A = 88 %, B = 82 %) yield (A = 105 mg, 0.30 mmol, B = 97 mg, 0.28 
mmol) from the reaction of N-chloro-N-(phenylmethoxy)-N'-(phenylmethyl)urea 31 (A or 
B = 100 mg, 0.34 mm) with spiro[2.4]hepta-4,6-diene (A = 0.172 ml, 1.71 mmol or B = 
0.037 ml, 0.37 mmol) via general procedure C. Rf = 0.68 (3:2, hexanes: ethyl acetate); 
1H-NMR (400 MHz, CDCl3): δ 7.48 – 7.45 (m, 2H), 7.37 - 7.23 (m, 8H), 6.31 (dd, J = 
5.8, 2.1 Hz, 1H), 6.12(ddd, J = 5.8, 2.4, 0.6 Hz, 1H), 5.05 (d, J = 11.1 Hz, 1H), 4.96 (d, J 
= 11.1 Hz, 1H), 4.62 (d, J = 14.9 Hz, 1H), 4.50 (d, J = 14.9 Hz, 1H), 3.17 (dd, J = 2.3, 2.3 
Hz, 1H), 2.95 (dd, J = 2.1, 2.1 Hz, 1H), 0.66 - 0.60 (m, 1H), 0.58 - 0.52 (m, 1H), and 0.48 
- 0.42 (m, 2); 13C-NMR (101 MHz, CDCl3): δ 158.8, 138.5, 138.0, 136.6, 136.0, 129.9, 
128.5, 128.3, 128.2, 127.4, 78.3, 70.3, 64.3, 50.1, 33.6, 10.6, and 7.9; IR (film) 3062, 
3029, 2931, 1660, 1494, 1453, 1437, 1409, 1385, 1354, 1235, 1207, 1190, 1072, 1015, 
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(±)-(5R, 1S) 8-(1-methylethylidene)-2-(phenylmethoxy)-4-(phenylmethyl)-2,4-
diazabicyclo[3.2.1]oct-6-en-3-one (32h)  
 
 
Prepared in (A = 85 %, B = 73 %) yield (A = 105 mg, 0.29 mmol, B = 91 mg, 0.25 
mmol) from the reaction of N-chloro-N-(phenylmethoxy)-N'-(phenylmethyl)urea 31 (A or 
B = 100 mg, 0.34 mm) with 6,6-dimethylfulvene (A = 0.207 ml, 1.71 mmol or B = 0.045 
ml, 0.37 mmol) via general procedure C. Rf = 0.65 (3:2, hexanes: ethyl acetate); 1H-NMR 
(400 MHz, CDCl3): δ 7.52 – 7.49 (m, 2H), 7.39 - 7.24 (m, 8H), 6.38 (ddd, J = 5.9, 2.2, 
0.5 Hz, 1H), 6.20 (ddd, J = 5.9, 2.6, 0.8 Hz, 1H), 5.06 (d, J = 11.4 Hz, 1H), 4.98 (d, J = 
11.4 Hz, 1H), 4.70 (d, J = 14.9 Hz, 1H), 4.48 (d, J = 14.9 Hz, 1H), 4.35 (ddd, J = 2.3, 1.5, 
0.8 Hz, 1H), 4.08 ((ddd, J = 2.2, 1.5, 0.5 Hz, 1H), 1.40 (s, 3H), and 1.38 (s, 3H); 13C-
NMR (101 MHz, CDCl3): δ 159.2, 138.2, 138.1, 137.0, 136.1, 131.3, 129.8, 128.5, 
128.4, 128.3, 128.2, 127.4, 118.7, 78.3, 65.0, 58.0, 50.1, 19.6, and 19.3; IR (film) 3062, 
3029, 2915, 1663, 1495, 1439, 1406, 1373, 1352, 1323, 1264, 1237, 1206, 1190, 1133, 
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(±)-(5R, 1S) 2-(phenylmethoxy)-4-(phenylmethyl)-2,4-diazabicyclo[3.2.2]non-6-en-3-
one (32i)  
 
 
Prepared in (A = 58 %, B = 43 %) yield (A = 336 mg, 1.0 mmol, B = 49 mg, 0.14 mmol) 
from the reaction of N-chloro-N-(phenylmethoxy)-N'-(phenylmethyl)urea 31 (A = 500 
mg, 1.72 mmol or B = 100 mg, 0.34 mmol) with 1,3-cyclohexadiene (A = 0.819 ml, 8.60 
mmol or B = 0.036 ml, 0.37 mmol) via general procedure C. Rf = 0.60 (3:2, hexanes: 
ethyl acetate); 1H-NMR (400 MHz, CDCl3): δ 7.48– 7.45 (m, 2H), 7.36 - 7.25 (m, 7H), 
7.24 – 7.19 (m, 1H), 6.28 (ddd, J = 8.6, 6.8, 1.2 Hz, 1H), 6.15 (ddd, J = 8.6, 7.0, 1.4 Hz, 
1H), 5.02 (s, 2H), 4.82 (d, J = 15.0 Hz, 1H), 4.35 (d, J = 15.0Hz), 3.78 (dddd, 6.8, 3.5, 
2.0, 2.0 Hz, 1H), 3.49 (ddd, J = 7.1, 4.1, 3.4 Hz, 1H), 2.19 – 2.12 (m, 1H), 1.99 – 1.93 
(m, 1H), and 1.57 – 1.42 (m, 2H); 13C-NMR (101 MHz, CDCl3): δ 159.4, 138.8, 136.4, 
133.9, 132.6, 129.8, 128.4, 128.3, 128.3, 128.1, 127.2, 78.1, 56.1, 52.8, 50.4, 25.8, and 
24.3; IR (film) 3029, 2930, 1741, 1642, 1494, 1447, 1423, 1354, 1303, 1236, 1194, 1154, 
















Prepared in (A = 91 %) yield (A = 105 mg, 0.31 mmol) from the reaction of N-chloro-N-
(phenylmethoxy)-N'-(phenylmethyl)urea 31 (A = 100 mg, 0.34 mm) with 2-methylfuran 
(A = 0.152 ml, 1.71 mmol) via general procedure C. Rf = 0.70 (3:2, hexanes: ethyl 
acetate); 1H-NMR (400 MHz, CDCl3): δ 7.49– 7.46 (m, 2H), 7.41 - 7.23 (m, 8H), 6.09 
(dd, J = 5.7, 1.1 Hz, 1H), 5.86 (d, J = 5.7 Hz, 1H), 5.30 (d, J = 1.3 Hz, 1H), 5.08 (d, J = 
11.2 Hz, 1H), 5.03 (d, J = 11.2 Hz, 1H), 4.98 (d, J = 16.1 Hz, 1H), 4.38 (d, J = 16.1 Hz 
1H), and 1.58 (s, 3H); 13C-NMR (101 MHz, CDCl3): δ 157.7, 138.9, 137.9, 136.2, 129.7, 
129.7, 128.6, 128.5, 128.5, 127.6, 127.2, 96.6, 92.6, 78.9, 45.5, and 19.8; IR (film) 3030, 
2939, 1674, 1604, 1495, 1453, 1429, 1394, 1356, 1282, 1263, 1219, 1167, 1142, 1110, 
1080, 1024, 997, 967, 918 cm-1; HR-ESIMS calculated for C20H20N2NaO3 (M+Na)+ 
















Prepared in (A = 69 %) yield (A = 83 mg, 0.23 mmol) from the reaction of N-chloro-N-
(phenylmethoxy)-N'-(phenylmethyl)urea 31 (A = 100 mg, 0.34 mm) with 2-
(hydroxymethyl)furan (A = 0.149 ml, 1.71 mmol) via general procedure C. Rf = 0.45 
(95:5, chloroform: methanol); 1H-NMR (500 MHz, CDCl3): δ 7.49 – 7.46 (m, 2H), 7.41 
– 7.28 (m, 8H), 6.27 (d, J = 5.8 Hz, 1H), 6.09 (dd, J = 5.8, 1.3 Hz, 1H), 5.35 (d, J = 1.3 
Hz, 1H), 5.23 (d, J = 10.2 Hz, 1H), 5.05 (d, J = 10.2 Hz, 1H), 4.68 (d, J = 15.2 Hz, 1H), 
4.53 (d, J = 15.2 Hz, 1H), 3.99 (dd, J = 12.6, 5.6 Hz, 1H), 3.87 (dd, J = 12.6, 8.0 Hz, 1H), 
and 1.71 (dd, J = 8.0, 5.6 Hz, 1H); 13C-NMR (126 MHz, CDCl3): δ 158.1, 137.1, 135.4, 
134.9, 132.3, 130.0, 128.9, 128.9, 128.6, 128.3, 127.9, 101.5, 89.4, 80.1, 61.4 and 48.0; 
IR (film) 3402 (br), 3030, 2924, 1663, 1536, 1495, 1440, 1409, 1358, 1311, 1229, 1138, 

















Prepared in (A = 92 %) yield (A = 127 mg, 0.316 mmol) from the reaction of N-chloro-
N-(phenylmethoxy)-N'-(phenylmethyl)urea 31 (A = 100 mg, 0.34 mm) with 3-
bromofuran (A = 0.154 ml, 1.71 mmol) via general procedure C. Rf = 0.45 (4:1, hexanes: 
ethyl acetate); 1H-NMR (400 MHz, CDCl3): δ 7.45 (dd, J = 7.6, 2.1 Hz, 2H), 7.41 - 7.25 
(m, 8H), 6.15 (d, J = 1.5 Hz, 1H), 5.29 (d, J = 1.6 Hz, 1H), 5.15 (d, J = 15.5Hz, 1H), 5.08 
(s, 1H), 5.04 (s, 2H), and 4.24 (d, J = 15.5 Hz, 1H); 13C-NMR (101 MHz, CDCl3): δ 
155.9, 136.1, 135.9, 129.8, 129.7, 128.8, 128.8, 128.5, 128.2, 127.8, 125.0, 94.2, 90.8, 
79.2, and 48.5; IR (film) 3030, 1685, 1594, 1495, 1453, 1439, 1407, 1356, 1330, 1236, 
1209, 1154, 1076, 1028, 999, 963, 923 cm-1; HR-ESIMS calculated for C19H17BrN2NaO3 












	   45	  




To a solution of (±)-(5R, 1S) 2-(phenylmethoxy)-4-(phenylmethyl)-2,4-
diazabicyclo[3.2.2]non-6-en-3-one 32i (0.096 g, 0.287 mmol) in methanol (5 mL) was 
added 10% Pd-C (0.010 g) and evacuated with house vacuum (water aspirator) and 
flushed with H2 gas through a balloon. And the reaction mixture was stirred under H2 gas 
balloon at room temperature for 4 hours. The complete consumption of [3.2.2] diaza-
bicyclononene 32i was confirmed by TLC (3:2, hexanes: ethyl acetate). The mixture was 
passed through celite bed and washed the a celite bed with methanol (20 mL). The 
collected filtrates were combined and concentrated reduced pressure. Purification by 
flash column chromatography (4:1 to 3:2, hexanes: ethyl acetate) afforded the product 39 
as a colorless oil (86 mg, 0.25 mmol, 89 % yield). Rf = 0.43 (3:2, hexanes: ethyl acetate); 
1H-NMR (400 MHz, CDCl3): δ 7.48 – 7.45 (m, 2H), 7.38 – 7.29 (m, 7H), 7.27 – 7.22 (m, 
1H), 5.04 (s, 2H), 4.53 (s, 2H), 3.47 (ddd, J = 7.3, 4.8, 2.5 Hz, 1H), 3.17 (ddd, J = 7.2, 
4.7, 2.5 Hz, 1H), 1.97 – 1.90 (m, 2H), 1.84 – 1.74 (m, 2H), and 1.62 – 1.52 (m, 4H); 13C-
NMR (101 MHz, CDCl3): δ 160.1, 138.9, 136.6, 129.7, 128.4, 128.3, 128.3, 128.2, 127.2, 
77.8, 56.8, 52.4, 51.4, 52.6, and 24.5; IR (film) 3028, 2941, 2861, 1640, 1494, 1449, 
1353, 1324, 1263, 1233, 1156, 1075, 1039, 1028, 998, 915 cm-1; HR-ESIMS calculated 










OBn H2, 10% Pd-C
MeOH, rt, 4h32i 39
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(±)-(5R, 1S) 4-hydroxy-2,4-diazabicyclo[3.2.2]nonan-3-one (40)  
 
 
To a solution of (±)-(5R, 1S) 2-(phenylmethoxy)-4-(phenylmethyl)-2,4-
diazabicyclo[3.2.2]non-6-en-3-one 32i (0.284 g, 0.849 mmol) in methanol (4.2 mL) and 
2M HCl (0.5 mL) was added 5% Pd/BaSO4 (0.080 g) and stirred the reaction under H2 
gas balloon at room temperature for 3 days. The complete consumption of [3.2.2] diaza 
bicyclononene 32i was confirmed by TLC (3:2, hexanes: ethyl acetate). The reaction 
mixture was filtered through a celite bed and washed the celite bed with methanol (15 
mL). The collected filtrates were combined and concentrated by rotary vapor. The crude 
product was purified by flash column chromatography (1:1 to 1:4, hexanes: ethyl acetate) 
to yield the product 40 as a colorless solid (70 mg, 0.44 mmol, 53 %). Rf = 0.53 (9:1, 
dichloromethane: methanol); mp = 162-170 °C; 1H-NMR (500 MHz, CDCl3): δ 7.92 (s, 
1H), 5.46 (brs, 1H), 3.71 – 3.68 (m, 1H), 3.27 – 3.24 (m, 1H), 2.323 – 2.25 (m, 2H), 2.08 
– 2.01 (m, 2H), and 1.86 – 1.76 (m, 4H); 13C-NMR (126 MHz, CDCl3): δ 161.3, 55.9, 
46.2, 27.3, and 25.2; IR (film) 3211, 3061, 2942, 2860, 1636, 1448, 1298, 1252, 1136, 
1088, 1063, 1042, 991, 965 cm-1; HR-ESIMS calculated for C7H12N2NaO2 (M+Na)+ 
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To a solution of (±)-(5R, 1S) 2-(phenylmethoxy)-4-(phenylmethyl)-2,4-
diazabicyclo[3.2.2]non-6-en-3-one 32i (0.126 g, 0.376 mmol) in CH3CN/H2O (2.5 mL, 
9:1, degassed under nitrogen) was added Mo(CO)6 (0.119 g, 0.450 mmol) and again 
degased under nitrogen. The reaction mixture was vigorously stirred and heated to reflux 
for 4 hours under nitrogen. The complete consumption of [3.2.2] diaza bicyclononene 32i 
was confirmed by TLC (3:2, hexanes: ethyl acetate). The crude reaction mixture was 
filtered through a celite bed and washed the celite bed with ethyl acetate (20 mL). The 
collected filtrates were combined and concentrated by rotary vapor. The crude product 
was purified by flash column chromatography (3:2 to 1:1, hexanes: ethyl acetate) to 
afford product 41 as a white solid (73 mg, 0.32 mmol, 85 %). Rf = 0.10 (1:4, hexanes: 
ethyl acetate); mp = 176.2-179.0 °C; 1H-NMR (400 MHz, CDCl3): δ 7.34 – 7.22 (m, 5H), 
6.42 (ddd, J = 8.4, 6.9, 1.4 Hz), 6.16 (ddd, J = 8.6, 7.1, 1.4 Hz, 1H), 5.72 (d, J = 6.4 Hz, 
1H), 4.81 (d, J = 15.2 Hz, 1H), 4.43 (d, J = 15.2 Hz, 1H), 3.57 – 3.50 (m, 2H), 2.32 – 
2.16 (m, 2H), and 1.73- 1.62 (m, 2H); 13C-NMR (101 MHz, CDCl3): δ 158.5, 139.3, 
133.9, 131.7, 128.4, 127.9, 127.0, 52.3, 50.1, 45.2, 28.5, and 26.7; IR (film) 3263, 3178, 
3033, 2954, 2928, 1634, 1493, 1451, 1428, 1356, 1329, 1283, 1270, 1252, 1193, 1150, 















	   48	  
(M+H)+ 229.1335; observed 229.1336. 
________________________________________________________________________ 
 
(±)-(1S, 5R, 6R, 7S) 6,7-dihydroxy-2-(phenylmethoxy)-4-(phenylmethyl)-2,4-




To a solution of (±)-(5R, 1S) 2-(phenylmethoxy)-4-(phenylmethyl)-2,4-
diazabicyclo[3.2.2]non-6-en-3-one 32i (0.170 g, 0.50 mmol) in CH3CN : H2O : acetone 
(1 mL : 1 mL: 2 mL) was added NMO (0.25ml, 1.00 mmol), and OsO4 (0.7 ml, 1% in 
H20) and stirred at room temperature for 16 hours. The complete consumption of [3.2.2] 
diaza bicyclononene 32i was confirmed by TLC (3:2, hexanes: ethyl acetate). To the 
reaction mixture was added sodium hydrosulfite (0.50 g) and stirred the reaction mixture 
for 1hour. The reaction mixture was filtered and the filtrate was neutralized to pH 7 with 
1N H2SO4 and the solvents were removed under rotary vapor and the pH was further 
adjusted to 2. The solution was extracted with ethyl acetated (200 mL) and dried over 
Na2SO4 and concentrated under rotary vapor to obtain product 42 as a colorless solid 
(140 mg, 0.38 mmol, 75 %). Rf = 0.45 (1:4, hexanes: ethyl acetate); mp = 184.5-186.8 
°C; 1H-NMR (500 MHz, (CD3)2SO):  δ 7.43 – 7.41 (m, 2H), 7.39 – 7.29 (m, 7H),  7.28 – 













CH3CN : H2O : acetone (1:1:2)
rt, 16h32i 42
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1H), 4.84 (d, J = 5.0 Hz, 1H), 4.50 (d, J = 15.0 Hz, 1H), 4.38 (d, J = 15.0 Hz, 1H), 3.89 – 
3.86 (m, 1H), 3.72 – 3.69 (m, 1H), 3.47 (ddd, J = 5.0, 2.5, 2.5 Hz, 1H), 3.05 – 3.03 (m, 
1H), 1.92 – 1.78 (m, 2H), 1.64 – 1.58 (m, 1H), and 1.52 – 1.46 (m, 1H); 13C-NMR (126 
MHz, (CD3)2SO): δ 158.3, 139.5, 136.7, 129.8, 128.9, 128.7, 128.7, 128.2, 127.6, 77.0, 
67.6, 66.5, 61.4, 56.9, 52.2, 21.2, and 20.7; IR (film) 3427, 3233, 2951, 1610, 1472, 
1455, 1432, 1406, 1381, 1357, 1296, 1270, 1243, 1186, 1135, 1081, 1062, 1026, 993, 





(±)-(1S, 5R, 6R, 7S) 6,7-dioxo-2-(phenylmethoxy)-4-(phenylmethyl)-2,4-
diazatricyclo[3.3.1.0]nonan-3-one (43)17  
 
 
To a solution of (±)-(5R, 1S) 2-(phenylmethoxy)-4-(phenylmethyl)-2,4-
diazabicyclo[3.2.2]non-6-en-3-one 32i (0.080 g, 0.239 mmol) in dry dichloromethane 
(1.2 mL) was added the solution of dimethyldioxirane (DMDO) in acetone (1.5 equiv, ca. 
0.07M) at -45 °C at allowed to room temperature for overnight. Additional DMDO (1.5 
equiv, ca. 0.07M) was added at at -45 °C and allowed to come room temperature for 24 











-45 0°C  to rt, 36h32i 43
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TLC (3:2, hexanes: ethyl acetate). The crude product was purified by flash column 
chromatography (4:1 to 3:2, hexanes: ethyl acetate) to yield product 43 as a colorless oil 
(66 mg, 0.19 mmol, 79 %). Rf = 0.45 (3:2, hexanes: ethyl acetate); 1H-NMR (500 MHz, 
CDCl3): δ 7.49 – 7.47 (m, 2H), 7.40 – 7.32 (m, 7H), 7.30 – 7.26 (m, 1H), 5.05 (s, 2H), 
4.87 (dd, J = 14.8, Hz, 1H), 4.35 (dd, J = 14.8 Hz, 1H), 3.70 (td, J = 6.9, 2.3 Hz, 1H), 
3.49 (td, J = 6.9, 2.3 Hz, 1H), 3.25 (dd, J = 4.9, 4.9 Hz, 1H), 3.08 (dd, J = 4.8, 4.8 Hz, 
1H), 1.90 – 1.85 (m, 1H), 1.78 – 1.70 (m, 2H), and 1.69 – 1.63 (m, 1H); 13C-NMR (126 
MHz, CDCl3): δ 159.4, 138.3, 136.0, 130.0, 128.6, 128.6, 128.4, 128.3, 127.6, 78.1, 59.6, 
53.5, 53.3, 51.1, 50.3, 24.1, and 22.7; IR (film) 3028, 2939, 1642, 1494, 1447, 1420, 
1351, 1233, 1202, 1108, 1073, 1016, 985, 946, 908 cm-1; HR-ESIMS calculated for 
C21H23N2O3 (M+H)+ 351.1703; observed 351.1703. 
 
________________________________________________________________________ 
    




To a solution of (±)-(5R, 1S) 2-(phenylmethoxy)-4-(phenylmethyl)-2,4-





OBn LiAlH4, 2M solution in THF
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mL) was added the solution of LiAlH4 (2 Molar solution in THF, 0.268 mL, 0.537 mmol) 
at 0 °C and stirred the reaction at room temperature for 1 hour. The complete 
consumption of [3.2.2] diaza bicyclononene 32i was confirmed by TLC (3:2, hexanes: 
ethyl acetate). The crude product was purified by flash column chromatography (3:2 to 
1:1, hexanes: ethyl acetate) to provide the product 45 as a light green oil (83 mg, 0.26 
mmol, 57 %). Rf = 0.38 (3:2, hexanes: ethyl acetate); 1H-NMR (500 MHz, CDCl3): δ 
7.37 – 7.27 (m, 9H), 7.24 – 7.21 (m, 1H), 5.94 (dd, J = 10.2, 1.3 Hz, 1H), 5.76 (dt, J = 
10.3, 3.7 Hz, 1H), 5.36 (brs, 1H), 4.72 (s, 2H), 3.63 (d, J = 13.3 Hz, 1H), 3.50 (dd, J = 
4.3, 1.8 Hz, 1H), 3.48 (d, J = 13.3, 1H), 3.27 (m, 1H), 2.20 (s, 3H), 2.01 – 1.98 (m, 1H), 
1.77 – 1.70 (m, 1H), and 1.66 – 1.54 (m, 2H); 13C-NMR (126 MHz, CDCl3): δ 140.0, 
137.9, 135.5, 128.7, 128.4, 128.3, 128.2, 127.8, 127.6, 126.8, 76.6, 59.4, 57.5, 54.4, 38.0, 
24.6, and 17.7; IR (film) 3026, 2930, 2856, 2787, 1602, 1494, 1452, 1389, 1363, 1298, 
1205, 1140, 1026, 989, 909 cm-1; HR-ESIMS calculated for C21H27N2O (M+H)+ 
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Scheme 3.1.1. Proposal for the oxidative 1,4-diamination of dienes 
 
 
               Generation of daiaza-oxyallyl cationic reactive intermediates from N-chloro 
ureas (chapter 2) is a novel and valuable method for the preparation of 1,4-diamines, a 
prominent motif found in bio-relevant molecules. Despite its importance for the 1,4-
diamination of cylic dienes using asymmetric N-chloro urea reagents,1 this method 
suffers from limited substrate scope and poor regioselectivity with mono-substituted 
furans by providing nearly 1:1 ratio of regio-isomers of the desired products. Moreover, 
the diaza-allyl cationic reactive intermediates did not react with acyclic dienes or furans 
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to develop an alternative method with various substrates, we have hypothesized that 
direct oxidation of symmetric ureas could deliver the desired reactive diaza-allyl cationic 
intermediate, and incorporating additional stabilizing (OBn) group could result in further 
stabilization of the putative intermediate, leading to longer lifetimes and a broader 
substrate scope.  
            
               Hypervalent iodine reagents have found widespread use in organic synthesis 
due to: 1) mild oxidizing nature, 2) low toxicity, 3) commercially availability and 4) 
stabilty.2-7 Additionally, we inspired by their effectiveness for the direct generation of 
stabilized N-acylnitrenium ions8-10 from the oxidation of O-alkyl hydroxamates. 
Therefore, we envisioned that the required diaza-oxyallyl cationic reactive intermediate 
could be generated via series of deprotonation and oxidation events and which would be 
trapped in situ with 1,3-conjugated dienes to provide the desired 1,4-diamination. 
 
3.2 Preliminary Experiment and Optimization of Oxidative 1,4-Diamination 
                  Armed with the hypothesis, we subjected symmetric N,N’-dibenzyloxy urea 
45 to oxidation with phenyl iododiacetate (BAIB) in the presence of  furan, and sodium 
salt of 2,2,3,3-tetrafluororpropanol (TFP/TFP-Na) as a base, and found the desired 1,4-
diamino cycloadduct in 40% yield (Table 3.2.1, entry 9). Encouraged by the preliminary 
experimental results for this cycloaddition reaction, we further directed our efforts to 
optimize the reaction conditions and explore the substrate scope with various 1,3-
conjugated dienes.  
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1 PhI(OCOCF3)2 5 3 h 0 °C --- 
2 PhI(OH)(OTs) 5 3 h 0  --- 
3 PhI(tBuCO2O)2 5 3 h 0  52 
4 PhI(OAc)2 5 3 h 0  70 
5 PhI(OAc)2 5 3 h -20  49 
6 PhI(OAc)2 5 3 h 25  67 
7 PhI(OAc)2 5 2 h 0  64 
8 PhI(OAc)2 5 6 h 0  54 
9 PhI(OAc)2 5 ~ 1 min 0  40 
10 PhI(OAc)2 2 3 h 0  70 
11 PhI(OAc)2 0.5 3 h 0  42 
12 PhI(OAc)2 1.1 3 h 0  56 
13c PhI(OAc)2 1 3 h 0  69c 
a2.0 equiv. of oxidant was used in each case, bYield based upon stoichiometry of the urea. c 
Reaction was conducted by adding PhI(OAc)2 to a solution of 2-methylfuran 48, the urea 45, and 
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               The yield of the cycloadduct was significantly increased when the urea 45 was 
added slower or equal to its consumption rate in the reaction (Table 3.2.1, entry 4 vs. 
entry 9), presumably it’s due to the competitive oxidative decomposition of the diene 
with hypervalent iodine reagent. Screening of alternative hypervalent iodine reagents like 
PIFA, Ph(Oh)(OTs) and PhI(tBuCO2O)2  (Table 3.2.1) as oxidizing agents diminished the 
product yield and found that the phenyl iododiacetate (BAIB) as the optimal oxidant. 
Using other solvents (CH3CN) lowered the yield and found that TFP as the optimal 
solvent. When the reaction was conducted in the absence of base (TFP-Na) the yield of 
the product was diminished (56% cf. 70%) (Table 3.2.1, entry 4 and 9). A marginal effect 
on the yield of the cycloadduct was observed by lowering the use of the diene 
concentarion from 5.0 to 1.1 (Table 3.2.1, entry 4 and 12), equivalents. Moreover, slow 
addition of oxidant to the diene and urea had no significant effect on the yield of the 
product in this case.  
 
3.3 Exploring the Substrate Scope of the Oxidative 1,4-Diamination 
          With optimized conditions identified, we conducted a study of the substrate scope 
with various 1,3-conjugated dienes. It is common use of cyclic and aromatic dienes as 
optimal substrates in [4+3] cycloaddition of allylic cations and related species. Similarly, 
cyclic dienes and aromatic dienes underwent successfully oxidative diaza-[4+3] 
cycloadition reaction and furnished very good to excellent yields of the 1,4-diminated 
products in all cases. However, in order to achieve the best results with oxidatively labile 
dienes and electron-rich dienes (49d, 49j) slow addition of the oxidant (BAIB) to a 
solution of diene, base and urea was essential.  
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Table 3.3.1. Scope of the Oxidative 1,4-Diamination Reactions of N,N′- 
Dibenzyloxyurea with Cyclic Aromatic Dienes 
 
 
(a) Conditions: A = slow addition of urea to 5.0 equiv of diene; B = slow addition of urea to 1.1 
equiv of diene; C = slow addition of the PhI(OAc)2 to diene (5.0 equiv) and urea; D = slow 

































A: 91% A: 90%
TFP-Na (2.0 eq), PhI(OAc)2
diene (5 equiv or 1.1 equiv)
TFP, 0 °C
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               In our previous studies using N-chloro urea diamination agents, the diaza-[4+3] 
cycloaddition reaction of  furans substituted with electron-withdrawing groups, like 
carboxylate or a MIDA boronates were met with failure. Conversely, both methyl 2-furan 
carboxylate and 3-MIDA boronate substituted furan provided good to excellent yields of 
the desired diaminated product (49h, 49k). Presumably this is due to a longer lifetime of 
the reactive diaza-allyl cationic intermediate by additional stabilization of the O-benzyl 
stabilizing group. In addition, these dienes demonstrated high degree of functionality 
compatible for the reaction conditions and moreover the cyloadducts have greater 
potential for further functionalization. Next, we screened the cyclic but nonaromatic 
dienes with the optimized conditions. Dienes like cyclopentadiene, phellandrene, 2,2,2-
spiroheptadiene, fulvene and cyclohexadiene (49c, 49l, 49m, 49n, 49o) provided good 
yields of the diaminated cycloadduct. To achieve the better results with 2,2,2-
spiroheptadiene, and fulvene (49m, 49n) the slow addition of the BAIB was required to 
the mixture of diene, base and urea in TFP solvent due to instability of the dienes with the 
oxidant. A control experiment revealed that indeed these dienes decomposed upon 
treatment with BAIB in the absence of the urea. Cycloaddition of fulvene provided 
exclusively 1,4-diaminated products over the 1,2-diamination, thus makes us to propose 
diaza-oxyallyl cation as an intermediate in [4+3] cycloaddition reaction. Cyclohexadiene 
derivatives furnished good yields of the cycloadducts with urea (49l, 49o). Cycloaddition 
of Phellandrene (49l) was diastereoselctive (dr = 70:30) for approach opposite of the 
isopropyl substituent.  
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3.4 Oxidative Diamination of Acyclic Dienes 
 
 
Scheme 3.4.1. Oxidative 1,4-Diamination of Acyclic Dienes 
 
                        Usually in [4+3] cycloaddition reactions, acyclic dienes are not compatible 
reactants including aza- and diaza-oxyallyl cations.11 To our delight, the reaction of urea 
45 with 2,3-dimethylbutadiene 50 and isoprene 52 provided fair to good yields. In case of 
2,3-dimethylbutadiene 50 the higher yield of the diaminated product is attributed due to 
the greater population of the reactive s-cis conformation of the diene. The mass balance 
of this reaction with acyclic dienes, likely to account with other aminated products but all 
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3.5 Intramolecular Oxidative Diamination Reaction 
            Carbon-Nitrogen (C-N) bond formation via intramolecular tethering of amination 
agents is an effective strategy in C-H functionalization as well as in 1,2-diamination 
reactions due to anticipated regio- and stereoslectivity of the product.12,13 Intramolecular 
diamination with N-chlorourea substrates were complicated in our previous studies due to 
the competitive halogenation of the furan. It was our vision that direct oxidation of 
intramolecularly tethered amination agent with diene would provide the intramolecular 
diaza-[4+3] cycloaddition reaction by avoiding the prefunctionalization of the urea. The 
required urea substrate 54 was prepared in one step from a known hydroxylamine14 and 
subjected to oxidative diamination reaction conditions. Indeed oxidation of the urea with 
the established conditions led to the intramolecular diaza-[4+3] cycloaddition reaction 
and provided the desired ploy heterocyclic product 55. 
 
 
Scheme 3.5.1. Intramolecular Oxidative 1,4-diamination reaction for ployheterocycles 
 
3.6 Mechanistic Proposal for the Oxidative 1,4-Diamination 
                  We propose the mechanistic pathway of the 1,4-diamianation as a result of a 
formal [4+3] cycloaddition of diaza-oxyallyl cation (2π) and a diene (4π). In order to 
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cation could generate from deprotonation and oxidation of the urea 45 (Schem 3.6.1), 
which can happen in any order. When reaction was performed with 2-methyl furan (48a), 
two by-products 56 and 57 (Schem 3.6.1) were formed, and this observation suggests that 
the order of events could play an important role in the product distribution. Since optimal 
results were obtained when the rate of addition of urea is equivalent or slower than the 
rate of consumption of the imidate 58 (Schem 3.6.1), it suggests that rate of addition is 
very important for this process. Moreover this observation was supported by formation of 
a greater proportion of the oxime 56 in the crude mixture when the urea 45 is added 
rapidly [50:50, 58:56 (1 min addition) vs. 70:30, 58:56 (3 h addition)]. Hence it further 
suggests that oxidation to the nitrenium 59, decomposition of 59 to the nitrene 13(Schem 
3.6.1), aziridination of 2-methylfuran (48a), and ring opening of 61 is more favorable 
under these conditions. Alternatively, the ratio of the byproduct 56 to desired cycloadduct 
58 could be determined by competitive elimination vs. deprotonation of 59 to form the 
nitrene 60 or desired diaza-oxyallyl cationic intermediate 46 (Schem 3.6.1). Therefore, it 
is clear that without further mechanistic study either pathway cannot be ruled out. 
Although it is apparent that there is a competition between the nitrene 60 and the daiza-
oxyallyl cation 46 (Schem 3.6.1), in our optimized reaction conditions the desired 
diaminated product was favored. Currently our efforts are directed towards the 
investigation of this approach to the generation and application of O-alkoxynitrenes for 
the C-N bond formation. 
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               All reactions were carried out under an atmosphere of nitrogen in oven-dried 
glassware with magnetic stirring, unless otherwise specified. Dichloromethane was 
purified by passage through a bed of activated alumina. Cyclopentadiene was distilled 
from dicyclopentadiene immediately prior to use.  All other reagents and solvents were 
purchased from Sigma-Aldrich Chemical Company and used without any further 
purification.  2,2,3,3-tetrafluoropropan-1-ol was purchased from SynQuest and used 
without further purification.  TLC information was recorded on Silicycle glass 60 F254 
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Purification of reaction products was carried out by flash chromatography using Silicycle 
Siliaflash® P60 (230-400 mesh) or through a medium pressure liquid chromatography 
(MPLC), a Biotage® purification system equipped with 254 nm and 280 nm UV detectors 
and by using Biotage zip 10g Si gel column employing a hexane, ethyl acetate gradient 
for the mobile phase. The cartridges for Biotage purification system were purchased from 
Biotage®. 1H-NMR spectra were measured on Varian 400 (400 MHz), Varian MR400 
(400 MHz), or Varian 500 (500 MHz) spectrometers and are reported in ppm (s = singlet, 
d = doublet, t=triplet, q = quartet, m = multiplet, br = broad, dd = doublet of doublets, dt 
= doublet of triplets and td = triplet of doublets; integration; coupling constant(s) in Hz), 
using TMS as an internal standard (TMS at 0.00 ppm) in CDCl3 or (CD3)2SO as solvent. 
13C-NMR spectra were recorded on V400 or V500 spectrometer and reported in ppm 
using solvent as an internal standard (CDCl3 at 77.16 ppm) or (CD3CN at 118.26 ppm). 
Infrared (IR) spectra were recorded on a Nicolet 6700 FT-IR with a diamond ATR and 
data are reported as cm-1 (br = broad, s = strong). High-resolution mass spectra were 
obtained using an Agilent 6230 TOF LC/MS with an (atmospheric pressure photo-
ionization (APPI) or electrospray (ESI) source with purine and HP-0921 as an internal 
calibrants. The slow additions of urea or (diacetoxyiodo)benzene (BAIB) was performed 
with syringe pump (model: NE-300) purchased from the manufacturer of New Era Pump 
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Synthesis of N, N'-bis(phenylmethoxy)urea 45. 
 
 
                To a solution of O-Benzylhydroxylamine hydrochloride (20.0 g, 125.305 
mmol) in dichloromethane (313 mL) was added triethylamine (17.264 mL, 125.305 
mmol) at 0 °C and stirred for 10 minutes before the addition of 1,1′-Carbonyldiimidazole 
(10.159 g, 62.651 mmol) over a period of 15 minutes in 3 portions. The reaction mixture 
was stirred at room temperature for 24 hours. The reaction was quenched with water (100 
mL) and extracted with dichloromethane (3 x 400 mL). The combined organic phase was 
dried over anhydrous Na2SO4 and concentrated under reduced pressure. The crude 
product was purified via column chromatography (4:1 to 3:2, hexanes: ethyl acetate) to 
provide the colourless solid (14.1 g, 51.781 mmol, 82 %). Rf = 0.25 (3:2, hexanes: ethyl 
acetate); mp = 89.8 – 90.2 °C; 1H NMR (500 MHz, CDCl3): δ 7.54 (s, 2H), 7.39 – 7.35 
(m, 6H), 7.34 – 7.30 (m, 4H), and 4.79 (s, 4H); 13C NMR (126 MHz, CDCl3): δ 159.7, 
135.1, 129.2, 128.8, 128.7, and 78.8; IR (film): 3219, 3063, 3029, 2923, 2865, 1659, 
1485, 1453, 1355, 1305, 1208, 1157, 1114, 1071, 1027, 975, 931, 906 cm-1; HR-ESIMS 
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Preparation of 1-Propanol, 2,2,3,3-tetrafluoro-, sodium salt  (TFP-Na) 
To a solution of 2,2,3,3-tetrafluoropropanol (TFP) (178 ml, 1M), was added freshly cut 
pieces of sodium (4.1 g) under nitrogen at room temperature over a period of 4 hours. 
The resulting mixture was stirred for additional 4 hours and the reaction was concentrated 
under vacuum using a rotary evaporator at 50 0 °C (water bath temperature). The round 
bottom flask containing TFP-Na product was flushed with nitrogen before removing the 
flask from rotary evaporator and the residual solvent was removed under vacuum for 2 
days to obtain TFP-Na as a white solid (24.0 g, 155.844 mmol, 87 %). The TFP-Na 




General procedure A and B (Normal Addition): Slow addition of urea for the 
cycloaddition reaction of dienes in 2,2,3,3-Tetrtafluoro-1-propanol 
 
 
To a solution of CHF2CF2CH2OH (0.28 M with respect to urea) and CHF2CF2CH2ONa 
(2.0 equiv) was added (diacetoxyiodo)benzene (DIB) (2.0 equiv.) and corresponding 
cyclic dienes 49 (A = 5.0 equiv or B = 1.0 equiv) dropwise at 0 °C. A solution of urea 45 
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°C over a period of 3.0 hours using a syringe pump. The reaction mixture was stirred 
additional 30 minutes at 0 °C for the complete consumption of urea, which was observed 
by TLC (4:1, hexanes: ethyl acetate). The volatiles were removed under reduced pressure 
and the residue was dissolved in ethyl acetate (50 mL), washed with water (50 mL) and 
separated the two layers. The extraction was repeated with aqueous layer (50 mL) and 
ethyl acetate (2 x 50 mL). The combined organic phase was dried over anhydrous MgSO4 
or Na2SO4 and concentrated under reduced pressure. The crude product was purified 
through Biotage by using Biotage zip 10g Si gel column employing a hexane, ethyl 
acetate gradient for the mobile phase.  
________________________________________________________________________ 
 
General procedure C and D (Inverse addition): Slow addition of 
(diacetoxyiodo)benzene (DIB) for the cycloaddition reaction of dienes in 2,2,3,3-
Tetrtafluoro-1-propanol. 
    
To a solution of CHF2CF2CH2OH (0.28 M with respect to urea) and CHF2CF2CH2ONa 
(2.0 equiv) was added urea 45 (0.367 mmol (1.0 equiv) corresponding cyclic dienes 49 
(A = 5.0 equiv or B = 1.0 equiv) dropwise at 0 °C. A solution of the 
(diacetoxyiodo)benzene (DIB) (2.0 equiv.) in anhydrous CH3CN (14.0 mL/0.734 mmol 
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The reaction mixture was stirred additional 30 minutes at 0 °C for the complete 
consumption of urea, which was observed by TLC (4:1, hexanes: ethyl acetate).  The 
volatiles were removed under reduced pressure and the residue was dissolved in ethyl 
acetate (50 mL), washed with water (50 mL) and separated the two layers. The extraction 
was repeated with aqueous layer (50 mL) and ethyl acetate (2 x 50 mL). The combined 
organic phase was dried over anhydrous MgSO4 or Na2SO4 and concentrated under 
reduced pressure. The crude product was purified through Biotage by using Biotage zip 







Prepared via general procedure A and B in (A = 70 % or B = 56 %) yield (A = 90 mg, 
0.25 mmol or B = 73 mg, 0.20 mmol) from the reaction of N, N'-bis(phenylmethoxy)urea 
45 (A = 100 mg, 0.36 mmol or B = 100 mg, 0.36 mmol) with 2-methylfuran (A = 0.163 
mL, 1.83 mmol or B = 0.03 mL, 0.36 mmol) as a pale yellow oil. Rf = 0.33 (4:1, hexanes: 
ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.47 – 7.45(m, 4H), 7.40 – 7.32 (m, 6H), 
6.36 (d, J = 0.8, 2H), 5.25 (dd, J = 0.8, 0.8, 2H), 5.15 (d, J = 9.9 Hz, 1H), 5.06 (d, J = 
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NMR (126 MHz, CDCl3): 161.8, 137.4, 135.9, 135.3, 133.0, 129.7, 129.6, 128.7, 128.7, 
128.6, 128.5, 100.3, 92.3, 79.9, 78.7, and 18.8; IR (film): 3031, 2939, 2879, 1725, 1586, 
1496, 1453, 1384, 1368, 1326, 1263, 1201, 1174, 1132, 1081, 1027, 986, 922 cm-1; HR-
ESIMS calculated for C20H21N2O4 (M+H)+ 353.1496; observed 353.1497. 
 
 




Prepared via general procedure A and B in (A = 91 % or B = 88 %) yield (A = 113 mg, 
0.33 mmol or B = 115 mg, 0.34 mmol) from the reaction of N, N'-
bis(phenylmethoxy)urea 45 (A = 100 mg, 0.36 mmol or B = 100 mg, 0.36 mmol) with 
furan (A = 0.134 mL, 1.83 mmol or B = 0.026 mL, 0.36 mmol) as a white solid. Rf = 
0.25 (4:1, hexanes: ethyl acetate); mp = 94.3 – 94.9 °C; 1H NMR (500 MHz, CDCl3): δ 
7.46 – 7.44 (m, 4H), 7.41 – 7.34 (m, 6H), 6.34 (dd, J = 0.8, 0.8 Hz, 2H), 5.25 (dd, J = 0.8, 
0.8 Hz, 2H), 5.03 (d, J = 11.1 Hz, 2H), 4.94 (d, J = 11.1 Hz, 2H); 13C NMR (126 MHz, 
CDCl3): δ 160.2, 135.8, 133.6, 129.6, 128.8, 128.5, 92.6, and 78.8; IR (film): 3093, 3025, 
2946, 2893, 1727, 1582, 1495, 1472, 1454, 1369, 1357, 1332, 1313, 1207, 1182, 1138, 
1075, 1092, 998, 970, 952, 921 cm-1; HR-ESIMS calculated for C19H18KN2O3 (M+K)+ 
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Prepared via general procedure A and B in (A = 90 % or B = 77 %) yield (A = 1.112 gm, 
3.30 mmol or B = 95 mg, 0.28 mmol) from the reaction of N, N'-bis(phenylmethoxy)urea 
45 (A = 1.0 gm, 3.67 mmol or B = 100 mg, 0.36 mmol) with cyclopentadiene (A = 1.55 
mL, 18.4 mmol or B = 0.03 mL, 0.36 mmol) as a colorless oil. Rf = 0. 43 (4:1, hexanes: 
ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.47 – 7.45 (m, 4H), 7.39 – 7.32 (m, 6H), 
6.33 (dd, J = 1.5, 1.5 Hz, 2H), 5.02 (d, J = 10.9 Hz, 2H), 4.88 (d, J = 10.9 Hz, 2H), 3.96 
(ddd, J = 4.5, 2.3, 1.3 Hz, 2H), 1.98 (dt, J = 11.2, 0.8 Hz, 1H), and 1.77 (dt, J = 11.2, 4.4 
Hz, 1H); 13C NMR (126 MHz, CDCl3): δ 161.1, 136.4, 136.2, 129.5, 128.43, 128.4, 78.1, 
65.0, and 38.8; IR (film): 3062, 3030, 2951, 2873, 1712, 1496, 1453, 1348, 1274, 1246, 
1208, 1176, 1143, 1081, 1049, 1018, 983, 923, cm-1; HR-ESIMS calculated for 













Prepared via general procedure C and D in (C = 64 % ) yield (C = 70 mg, 0.19 mmol) 
from the reaction of N, N'-bis(phenylmethoxy)urea 45 (C = 100 mg, 0.36 mmol) with 2,5-
dimethylfuran (C = 0.195 mL, 1.83 mmol) as a white solid. Rf = 0.35 (4:1, hexanes: ethyl 
acetate); mp = 119.4 – 120.8 °C; 1H NMR (500 MHz, CDCl3): δ 7.49 – 7.46 (m, 4H), 
7.39 – 7.32 (m, 6H), 6.30 (s, 2H), 5.17 (d, J = 10.0 Hz, 2H), 4.89 (d, J = 9.9 Hz, 2H), and 
1.64 (s, 6H); 13C NMR (126 MHz, CDCl3): δ 162.9, 136.4, 135.3, 129.7, 128.6, 128.4, 
100.1, 79.7, and 19.0; IR (film): 3093, 3065, 3033, 2992, 2869, 1773, 1717, 1595, 1496, 
1454, 1378, 1370, 1326, 1301, 1266, 1213, 1157, 1108, 1085, 1064, 1034, 1003 cm-1; 
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Prepared via general procedure A and B in (B = 55 %) yield (B = 86 mg, 0.21 mmol) 
from the reaction of N, N'-bis(phenylmethoxy)urea 45 (A = 100 mg, 0.36 mmol or B = 
106 mg, 0.38 mmol) with 3,4-bis(hydroxymethyl)furan (A = 0.134 mL, 1.83 mmol or B = 
0.040 mL, 0.38 mmol) as a colorless oil after purification of the crude product via column 
chromatography (95:5, chloroform: methanol). Rf = 0.18 (95:5, chloroform: methanol); 
1H NMR (500 MHz, CDCl3): δ 7.44 – 7.40 (m, 4H), 7.39 – 7.33 (m, 6H), 5.21 (s, 2H), 
5.02 (d, J = 11.2 Hz, 2H), 4.92 (d, J = 11.1 Hz, 2H), 4.28 (d, J = 14.1 Hz, 2H), 4.15 (d, J 
= 14.2 Hz, 2H), and 3.18 (brs, 2H); 13C NMR (126 MHz, CDCl3): δ 160.7, 141.4, 135.4, 
129.5, 128.9, 128.7, 94.1, 78.9, and 56.6; IR (film): 3392 (br), 3031, 2877, 1698, 1497, 
1454, 1355, 1266, 1209, 1137, 1082, 992, 917, 866 cm-1; HR-ESIMS calculated for 







Prepared via general procedure A and B in (A = 86 % or B = 81 %) yield (A = 125 mg, 
0.31 mmol or B = 117 mg, 0.29 mmol) from the reaction of N, N'-
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methyl 1-pyrrolecarboxylate (A = 0.206 mL, 1.83 mmol or B = 0.03 mL, 0.36 mmol) as 
an colorless oil. Rf = 0.15 (4:1, hexanes: ethyl acetate); 1H NMR at 90 °C (500 MHz, 
(CD3)2SO): δ 7.46 – 7.44 (m, 4H), 7.41 – 7.34 (m, 6H), 6.69 (dd, J = 1.6, 1.6 Hz, 2H), 
5.59 (dd, J =  1.5, 1.5 Hz, 2H), 4.92 (d, J = 11.0 Hz, 2H), 4.89 (d, J = 11.0 Hz, 2H) and 
3.68 (s, 3H); 13C NMR at 90 °C (126 MHz, (CD3)2SO): δ 160.4, 152.5, 136.3, 135.5, 
129.4, 128.7, 128.6, 77.9, 75.0 and 53.5; IR (film): 3031,  2954, 1717, 1584, 1496, 1441, 
1369, 1329, 1311, 1282, 1224, 1115, 1082, 970, 906 cm-1; HR-ESIMS calculated for 







Prepared via general procedure A and B in (A = 95 % or B = 65 %) yield (A = 153 mg, 
0.35 mmol or B = 104 mg, 0.24 mmol) from the reaction of N, N'-
bis(phenylmethoxy)urea 45 (A = 100 mg, 0.36 mmol or B = 100 mg, 0.36 mmol) with N-
Boc-pyrrole (A = 0.307 mL, 1.83 mmol or B = 0.061 mL, 0.36 mmol) as an colorless oil. 
Rf = 0.24 (4:1, hexanes: ethyl acetate); 1H NMR at 90 °C (500 MHz, (CD3)2SO): 7.46 – 
7.43 (m, 4H), 7.40 – 7.32 (m, 6H), 6.68 (dd, J = 1.5, 1.5 Hz, 2H), 5.60 (dd, J = 1.5, 1.5 
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151.2, 136.3, 135.5, 129.3, 128.6, 128.6, 81.9, 77.8, 75.0, and 28.3; IR (film): 3031, 
2975, 1715, 1497, 1454, 1366, 1327, 1313, 1287, 1258, 1222, 1163, 1111, 1082, 996, 







    
Prepared via general procedure A and B in (A = 58 %) yield (A = 85 mg, 0.21 mmol) 
from the reaction of N, N'-bis(phenylmethoxy)urea 45 (A = 100 mg, 0.36 mmol) with 
methyl 2-furoate (A = 0.196 mL, 1.83 mmol) as a colorless oil. Rf = 0.21 (4:1, hexanes: 
ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.48 – 7.44 (m, 2H), 7.41 – 7.32 (m, 8H), 
6.74 (d, J = 5.9 Hz, 1H), 6.53 (dd, J = 5.9, 1.2 Hz, 1H), 5.34 (d, J = 1.2 Hz, 1H), 5.16 (d, 
J = 9.7 Hz, 1H), 5.05 (d, J = 11.1 Hz, 1H), 4.96 (d, J = 9.6 Hz, 1H), 4.92 (d, J = 11.2 Hz, 
1H), 3.84 (s, 3H); 13C NMR (126 MHz, CDCl3): δ 164.1, 160.9, 135.5, 134.9, 134.8, 
134.1, 129.6, 129.5, 128.9, 128.7, 128.6, 128.4, 98.3, 92.9, 79.6, 78.8, and 53.4; IR 
(film): 3032, 2953, 1736, 1585, 1496, 1454, 1355, 1328, 1285, 1207, 1142, 1088, 996, 













   
Prepared via general procedure A and B in (A = 84 % or B = 68 %) yield (A = 129 mg, 
0.31 mmol or B = 104 mg, 0.25 mmol) from the reaction of N, N'-
bis(phenylmethoxy)urea 45 (A = 100 mg, 0.36 mmol or B = 100 mg, 0.36 mmol) with 3-
bromofuran (A = 0.165 mL, 1.83 mmol or B = 0.033 mL, 0.36 mmol) as a colorless oil. 
Rf = 0.35 (4:1, hexanes: ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.48 – 7.46 (m, 
2H), 7.45 – 7.42 (m, 2H), 7.41 – 7.33 (m, 6H), 6.28 (d, J = 1.5, 1H), 5.17 (dd, J = 1.5, 
0.5, 1H), 5.11 (s, 1H), 5.06 (d, J = 11.2 Hz, 1H), 5.02 (d, J = 11.2 Hz, 1H), 5.0 (d, J = 
11.2 Hz, 1H), 4.96 (d, J = 11.1 Hz, 1H); 13C NMR (126 MHz, CDCl3): δ 158.7, 135.6, 
135.5, 131.8, 129.8, 129.4, 128.9, 128.7, 128.6, 128.6, 125.1, 95.1, 93.5, 79.2, and 79.0; 
IR (film): 3031, 2936, 2878, 1717, 1587, 1496, 1454, 1350, 1265, 1187, 1141, 1110, 
1064, 992, 960, 917 cm-1; HR-ESIMS calculated for C19H17BrN2NaO4 (M+Na)+ 

















Prepared via general procedure C and D in (A = 66 % or B = 56 %) yield (C = 90 mg, 
0.24 mmol or D = 76 mg, 0.21 mmol) from the reaction of N, N'-bis(phenylmethoxy)urea 
45 (C = 100 mg, 0.36 mmol or D = 100 mg, 0.36 mmol) with furfuryl alcohol (A = 0.160 
mL, 1.83 mmol or B = 0.032 mL, 0.36 mmol) as a pale yellow oil. Rf = 0.23 (3:2, 
hexanes: ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.48 – 7.46 (m, 4H), 7.41 – 7.35 
(m, 6H), 6.46 (dd, J = 5.9, 1.2 Hz, 1H), 6.41 (d, J = 5.9 Hz, 1H), 5.31 (d, J = 1.2 Hz, 1H), 
5.15 (d, J = 10.1 Hz, 1H), 5.06 (d, J = 11.1 Hz, 1H), 4.96 (d, J = 10.2 Hz, 1H), 4.93 (d, J 
= 11.1 Hz, 1H), 3.94 (dd, J = 12.7, 6.1 Hz, 1H), 3.86 (dd, J = 12.7, 7.5 Hz, 1H), and 1.66 
(dd, J = 7.6, 6.2 Hz, 1H); 13C NMR (126 MHz, CDCl3): δ 161.9, 135.7, 135.1, 134.7, 
134.4, 129.9, 129.6, 129.0, 128.8, 128.6, 128.6, 101.8, 92.4, 79.6, 78.8, and 61.0; IR 
(film): 3435, 3031, 2934, 2880, 1706, 1586, 1496, 1454, 1332, 1274, 1191, 1066, 1000 
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(±)-(5R, 1S) 8-oxa-2-(phenylmethoxy)-4-phenylmethyl-2,4-dizabicyclo[3.2.1]oct-6-en-
3-one-6-MIDA boronate (49k) 
 
     
Prepared via general procedure A and B in (B = 80 %) yield (B = 177 mg, 0.36 mmol) 
from the reaction of N, N'-bis(phenylmethoxy)urea 45 (B = 134 mg, 0.49 mmol) with 
furan-3-boronic acid MIDA ester (B = 100 mg, 0.45 mmol) as a white solid after 
purification of the crude product via column chromatography (95:5 to 90:10, chloroform: 
methanol). Rf = 0.38 (9:1, chloroform: methanol); mp = decomposed at 182.0 °C; 1H 
NMR (500 MHz, CD3CN): δ 7.51 – 7.47 (m, 4H), 7.46 – 7.41 (m, 6H), 6.87 (dd, J = 1.3, 
0.5 Hz, 1H), 5.57 (dd, J = 1.3, 0.4 Hz, 1H), 5.51 (dd, J = 0.5, 0.5 Hz, 1H), 4.99 (dd, J = 
10.7 Hz, 1H), 4.95 (s, 2H), 4.92 (d, J = 10.7 Hz, 1H), 4.01 (d, J = 17.4 Hz, 1H), 3.90 (d, J 
= 17.5 Hz, 1H), 3.86 (d, J = 16.9 Hz, 1H), 3.57 (d, J = 16.9 Hz, 1H), and 2.78 (s, 3H);13C 
NMR (126 MHz, CD3CN): δ 168.3, 167.6, 160.5, 143.0, 135.9, 135.4, 129.8, 129.4, 
128.8, 128.7, 128.5, 128.5, 94.9, 93.2, 78.2, 78.1, 68.6, 62.9, 62.3, and 47.46; IR (film): 
3008, 2958, 1778, 1758, 1727, 1596, 1497, 1455, 1336, 1287, 1248, 1192, 1128, 1089, 
1033, 982, 964, 922, 895, 858 cm-1; HR-ESIMS calculated for C24H24BN3NaO8 (M+Na)+ 















Prepared via general procedure A and B in (A = 53 % or B = 54 %) yield (A = 79 mg, 
0.19 mmol or B = 80 mg, 0.20 mmol) from the reaction of N, N'-bis(phenylmethoxy)urea 
45 (A = 100 mg, 0.36 mmol or B = 100 mg, 0.36 mmol) with α-phellandrene (A = 0.294 
mL, 1.83 mmol or B = 0.058 mL, 0.36 mmol) as a colorless oil. Rf = 0.25 (4:1, hexanes: 
ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.47 – 7.44 (m, 4H), 7.38 – 7.31 (m, 6H), 
5.75 (dq, J = 7.1, 1.7 Hz, 1H), 5.03 (d, J = 10.8 Hz, 2H), 4.98 (d, J = 10.7 Hz, 1H), 4.96 
(d, J = 10.9 Hz, 1H), 3.56 – 3.54 (m, 2H), 2.12 – 2.07 (m, 1H), 1.93 – 1.88 (m, 1H), 1.67 
(d, J = 1.7 Hz, 3H), 1.16 – 1.07 (m, 2H), 0.65 (dd, J = 8.5, 6.7 Hz, 6H); 13C NMR (126 
MHz, CDCl3): δ 159.4, 142.8, 136.4, 136.3, 129.9, 129.8, 128.4, 128.4, 128.4, 124.5, 
78.0, 77.9, 62.0, 59.5, 42.9, 32.1, 29.9, 20.7, 20.1, and 19.4;	  IR (film): 3031, 2957, 2871, 
1671, 1496, 1496, 1453, 1387, 1368, 1208, 1158, 1082, 1056, 1000, 912 cm-1; HR-
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(±)-(5R, 1S) 2,4-Bis(phenylmethoxy)-2,4-diaza-spiro[bicyclo[3.2.1]oct-6-en-8,1'-
cyclopropan]-3-one (49m)  
 
  
Prepared via general procedure C and D in (C = 84 % or D = 82 %) yield (C = 112 mg, 
0.31 mmol or D = 109 mg, 0.30 mmol) from the reaction of N, N'-
bis(phenylmethoxy)urea 45 (C = 100 mg, 0.36 mmol or D = 100 mg, 0.36 mmol) with 
spiro[2.4]hepta-4,6-diene (C = 0.184 mL, 1.83 mmol or D = 0.036 mL, 0.36 mmol) as a 
off-white solid. Rf = 0.43 (4:1, hexanes: ethyl acetate); mp = 133.6 – 134.8 °C; 1H NMR 
(500 MHz, CDCl3): δ 7.45 – 7.42 (m, 4H), 7.37 – 7.30 (m, 6H), 6.45 (dd, J = 1.5, 1.5 Hz, 
2H), 5.01 (d, J = 11.1 Hz, 2H), 4.86 (d, J = 11.1 Hz, 2H), 3.08 (dd, J = 1.5, 1.5 Hz, 2H), 
0.56 - 0.52 (m, 2H), 0.44 - 0.41 (m, 2H); 13C NMR (126 MHz, CDCl3): δ 161.5, 138.0, 
136.2, 129.8, 128.4, 128.2, 78.1, 70.4, 32.5, 10.5, and 8.2; IR (film): 3026, 3003, 2922, 
2869, 1696, 1495, 1453, 1418, 1367, 1234, 1207, 1160, 1133, 1081, 1054, 1003, 937, 















Prepared via general procedure C and D in (C = 67 % or D = 69 %) yield (C = 93 mg, 
0.24 mmol or D = 97 mg, 0.26 mmol) from the reaction of N, N'-bis(phenylmethoxy)urea 
45 (C = 100 mg, 0.36 mmol or D = 100 mg, 0.36 mmol) with 6,6-dimethylfulvene (C = 
0.221 mL, 1.83 mmol or D = 0.045 mL, 0.36 mmol) as a pale yellow oil. Rf = 0.28 (4:1, 
hexanes: ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.49 - 7.46 (m, 4H), 7.39 - 7.31 
(m, 7H), 6.52 (dd, J = 1.5, 1.5 Hz, 2H), 5.02 (d, J = 11.4 Hz, 2H), 4.85 (d, J = 11.4 Hz, 
2H), 4.28 (dd, J = 1.6, 1.6 Hz, 2H), and 1.35 (s, 6H); 13C NMR (126 MHz, CDCl3): δ 
162.5, 138.1, 136.7, 129.7, 129.0, 128.4, 128.3, 122.3, 78.1, 64.9, and 19.5; IR (film): 
2923, 1709, 1496, 1453, 1372, 1333, 1266, 1207, 1140, 1054, 1000, 914, 867, cm-1; HR-
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Prepared via general procedure A and B in (A = 70 % or B = 54 %) yield (A = 91 mg, 
0.26 mmol or B = 700 mg, 1.99 mmol) from the reaction of N, N'-
bis(phenylmethoxy)urea 45 (A = 100 mg, 0.36 mmol or B = 1000 mg, 3.67 mmol) with 
1,3-cyclohexadiene (A = 0.175 mL, 1.83 mmol or B = 0.350 mL, 3.67 mmol) as a off-
white solid. Rf = 0.38 (4:1, hexanes: ethyl acetate); mp = 84.6 – 85.6 °C; 1H NMR (500 
MHz, CDCl3): δ 7.49 – 7.45 (m, 4H), 7.39 – 7.32 (m, 6H), 6.25 (dd, J = 5.1, 3.2 Hz, 2H), 
5.02 (d, J = 10.6 Hz, 2H), 4.98 (d, J = 10.7 Hz, 2H), 3.76 – 3. 72 (m, 2H), 2.10 – 1.99 (m, 
2H), and 1.53 – 1.42 (m, 2H); 13C NMR (126 MHz, CDCl3): δ 158.9, 136.1, 133.0, 129.9, 
128.5, 128.4, 78.1, 56.1, and 24.3; IR (film): 3030, 2933, 2868, 1669, 1496, 1453, 1397, 
1299, 1200, 1061, 1010, 980, 915, 868, cm-1; HR-ESIMS calculated for C21H22N2NaO3 
















 Prepared via general procedure A and B in (A = 63 %) yield (A = 82 mg, 0.23 mmol) 
from the reaction of N, N'-bis(phenylmethoxy)urea 45 (A = 100 mg, 0.36 mmol) with 2,3-
dimethyl-1,3-butadiene (A = 0.223 mL, 1.83 mmol) as a colorless oil. Rf = 0.20 (4:1, 
hexanes: ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.40 – 7.35 (m, 4H), 7.34 – 7.28 
(m, 6H), 4.81 (s, 4H), 3.69 (s, 4H), and 1.43 (s, 6H); 13C NMR (126 MHz, CDCl3): δ 
163.8, 135.9, 129.5, 128.4, 128.3, 124.9, 77.0, 58.1, and 18.0; IR (film): 3030, 2916, 
2858, 1714, 1496, 1453, 1396, 1369, 1270, 1209, 1081, 1001, 911 cm-1; HR-ESIMS 


















Prepared via general procedure A and B in (A = 37 %) yield (A = 46 mg, 0.13 mmol) 
from the reaction of N, N'-bis(phenylmethoxy)urea 45 (A = 100 mg, 0.36 mmol) with 2-
methyl-1,3-butadiene (A = 0.184 mL, 1.83 mmol) as a colorless oil. Rf = 0.52 (3:2, 
hexanes: ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.41 – 7.37 (m, 4H), 7.36 – 7.29 
(m, 6H), 5.29 – 5.26 (m, 1H), 4.82 (s, 2H), 4.81 (s, 2H), 3.79 – 3.77  (m, 2H), 3.68 (d, J = 
1.9 Hz, 2H), and 1.52 (d, J = 1.9 Hz, 3H); 13C NMR (126 MHz, CDCl3): δ 164.0, 136.0, 
135.8, 133.2, 129.5, 129.5, 128.4, 128.4, 128.3, 128.3, 119.1, 77.0, 77.0, 57.4, 52.4, and 
22.1; IR (film): 3030, 2930, 1710, 1496, 1453, 1396, 1368, 1238, 1208, 1156, 1106, 
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To a solution of O-3-(2-Furyl)propylhydroxylamine (0.580 g, 4.108 mmol) in 
dichloromethane (20.5 mL) was added triethylamine (1.145 mL, 8.212 mmol) at 0 °C and 
stirred for 10 minutes before the addition of 1-(4-nitrophenol)-N-(O-
benzylhydroxy)carbamate (10.159 g, 62.651 mmol). The reaction mixture was refluxed 
for 4 hours. The complete consumption of starting material was observed by TLC (4:1, 
hexanes: ethyl acetate). The reaction was quenched with water (50 mL) and extracted 
with dichloromethane (3 x 100 mL). The combined organic phase was dried over 
anhydrous Na2SO4 and concentrated under reduced pressure. The crude product was 
purified via column chromatography (4:1 to 3:2, hexanes: ethyl acetate) to provide the 
product 54 as colorless oil. Rf = 0.27 (3:2, hexanes: ethyl acetate); 1H NMR (500 MHz, 
CDCl3): δ 8.29 (s, 1H), 8.24 (s, 1H), 7.38 – 7.29 (m, 5H), 7.25 (dd, J = 1.9, 0.9 Hz, 1H), 
6.24 (dd, J = 3.2, 1.9 Hz, 1H), 5.95 (dd, J = 3.2, 0.9 Hz, 1H), 4.82 (s, 2H), 3.76 (t, J = 6.4 
Hz, 2H), 2.64 (t, J = 7.4, Hz, 2H), and 1.88 (q, J = 7.4, 6.4 Hz, 2H); 13C NMR (126 MHz, 
CDCl3): δ 160.5, 155.0, 141.0, 135.4, 129.3, 128.8, 128.6, 110.2, 105.3, 78.7, 75.8, 26.5, 
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1144, 1068, 1004, 929, 884 cm-1; HR-ESIMS calculated for C15H18N2NaO4 (M+Na)+ 
313.1159; observed 313.1176. 
 
Note: Substrates O-3-(2-Furyl)propylhydroxylamine14 and 1-(4-nitrophenol)-N-(O-
benzylhydroxy)carbamate15 were synthesized from known literature procedures. The 




Intramolecular cycloaddition in 2,2,3,3-Tetrtafluoro-1-propanol: 




To a solution of CHF2CF2CH2OH 1.598 mL (0.25 M with respect to urea) and 
CHF2CF2CH2ONa (0.123 g, 0.80 mmol) was added (diacetoxyiodo)benzene (DIB) (0.257 
g, 0.80 mmol) at 0 °C. A solution of urea 54 (0.116 g, 0.40 mmol) in anhydrous CH3CN 
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a syringe pump. The reaction mixture was stirred additional 30 minutes at 0 °C for the 
complete consumption of urea 54, which was observed by TLC (3:2, hexanes: ethyl 
acetate). The volatiles were removed under reduced pressure and the residue was 
dissolved in ethyl acetate (50 mL), washed with water (50 mL) and separated the two 
layers. The extraction was repeated with aqueous layer (50 mL) and ethyl acetate (2 x 50 
mL). The combined organic phase was dried over anhydrous MgSO4 or Na2SO4 and 
concentrated under reduced pressure. The crude product was purified through Biotage by 
using Biotage zip 10g Si gel column employing a hexane, ethyl acetate gradient for the 
mobile phase to afford product 55 as a white solid (95 mg, 0.33 mmol, 82 %). Rf = 0.15 
(3:2, hexanes: ethyl acetate); mp = 139.8 – 141.4 °C; 1H NMR (500 MHz, CDCl3): δ 7.47 
– 7.44 (m, 2H), 7.40 – 7.33 (m, 3H), 6.68 (d, J = 5.9 Hz, 1H), 6.55 (dd, J = 5.9, 1.5 Hz, 
1H), 5.22 (d, J = 1.2 Hz, 1H), 5.03 (d, J = 11.4 Hz, 1H), 4.88 (d, J = 11.4 Hz, 1H), 4.23 – 
4.19 (m, 1H), 3.99 (td, J = 11.9, 2.6 Hz, 1H), 2.12 – 2.07 (m, 2H), 2.04 – 1.93 (m, 1H), 
and 1.93 – 1.87 (m, 1H);	   13C NMR (126 MHz, CDCl3): δ 159.2, 135.8, 135.6, 134.5, 
129.6, 128.7, 128.5, 98.0, 91.8, 78.6, 70.7, 28.4, and 23.4; IR (film): 3103, 3012, 2964, 
2911, 2882, 1711, 1581, 1497, 1469, 1457, 1435, 1378, 1358, 1338, 1305, 1320, 1279, 
1253, 1227, 1196, 1138, 1092, 1048, 1029, 1007, 986, 955, 946, 903 cm-1; HR-ESIMS 
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Chapter 4: Dearomative Indole Cycloaddition Reactions of Diaza-Oxyallyl Cationic 





Figure 4.1.1. Indole core containing biologically active natural products and pharmaceutically 
designed molecules 
 
               Indole cores are ubiquitously present in numerous biologically active natural 
products and pharmaceuticals.1-6 2,3-diamino indole analogues are found in designed 
pharmaceuticals and the promising biological activity has brought significant interest 
from synthetic community to synthesize this heterocyclic motif. Imidazolo[4,5-b]indole 
15, 63 derivatives have been demonstrated to exhibit pronounced anti-inflammatory, 
antibacterial and antifungal activities.7-9 6H-indolo[2,3-b]quinoxaline 16 analogues 
comprise an important class of DNA intercalating agents10-12 and posses broad spectrum 
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antiarthritic  activities. There are few reported methods to construct the diamino indoles. 
These methods often involve multicomponent and multi step reactions that use 
potentially unstable organic azides as precursors.13-17 Despite the pharmacological 
importance of 2,3-diamino indole derivatives a straightforward synthesis of 2,3-diamino 
indoles has yet to be realized.  
 
Our Group work: 
 
This work: Hypothesis for the synthesis of Imidazolo- indolines 
 
Scheme 4.1.1. (3+2) Annulation of indoles with aza-oxyallyl cations 
 
                Wu and co-workers18 have recently reported synthesis of functionalized fused 
indoline compounds through diastereoselective dearomative (3+2)-cycloaddition 
reactions of substituted indoles with α-haloketone. This reaction proceeded via an 
oxyallyl cationic intermediate. Establishment of 1,4-diamination via a daiza-oxyallyl 
cationic  intermediate 19 (Chapter 2 and 3), and simultaneous discovery of the (3+2) 
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the analogous reaction of diaza-oxyallylic cations (Scheme 4.1.1). Inspired by our 
group’s previous development of an oxidative 1,4-diamination of 1,3-dienes, we 
envisioned that dearomative cycloaddition of the indole with oxidatively generated diaza-
oxyallyl cation would be a concise approach to access the 2,3-diaminoindoles. 
 




Scheme 4.2.1. Preliminary experiment for the dearomative indole (3+2) cycloaddition of 
diazaoxyallyl cation. 
 
                    The desired daiza-oxyallyl cationic intermediate in our previous oxidative 
1,4-diamination reactions was generated by using (diacetoxyiodo)benzene as an oxidant 
and trapped the intermediate in situ with dienes. Likewise, preliminary oxidative (3+2) 
reactions of 1,3-dimethylindole 68 with N,N-dibenzyloxy urea 18 and PhI(OAc)2 (BAIB) 
in 2,2,3,3-tetrafluoropropanol (TFP) furnished the desired cycloadduct 69 in 21% yield. 
Delighted by the preliminary results, we selected 1,3-dimehtylindole 68 as a model 
substrate for the optimization of the reaction. The addition of the oxidant (BAIB) in 
CH3CN, at a rate slower or equal to the rate of reaction of the indole improved the yield 
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equiv.) in CH3CN to the mixture of base (TFP-Na, 1.2 equiv.), indole (1.0 equiv.) and 
urea (2.0 equiv.) in TFP over 3 hours at 0 °C, was found to be the optimal reaction 
conditions, affording 79% of desired cycloadduct 69 (Table 4.2.1, entry 7). 
 
Table 4.2.1. Optimization of the Oxidative Cycloaddition of 1,3-Dimethyl Indole 68 









1 2 1.2 2 46 
2 1.2 1.2 1.2 58 
3 1 1.2 1.2 65 
4 1 1.5 1.2 68 
5 1.2 1.5 1.2 75 
6 1.3 1.5 1.2 77 
7 1.5 2 1.2 79 
8 1 1 --- 28 
9 1 1 1 58 
10b 1 1 1b 46 
11 1.5 2 2 79 
12 2 2 2 70 
13c 1 1 1 21 
aAll reactions are carried out  at 0 °C by slow addition of PhI(OAc)2 in CH3CN to a solution of 
urea over 3 hour, base (TFP-Na) and indole (1 equiv.), in tetrafluoropropanol and CH3CN. 
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4.3 Exploring the Substrate Scope of the Oxidative 2,3-Diamination of Indoles 
 
Table 4.3.1 Oxidative Cycloaddition of 1,3-Diubsubstituted Indoles 17 with N, N'-
bis(phenylmethoxy)urea 18a 
 
   aAll reactions were conducted by slow addition of a solution of BAIB (1.5 equiv.) over 3 hr to a 
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                 Oxidative (3+2)-reactions of C-3 alkyl substituted indoles 20m, 20n, provided 
high yield of the desired products. Substitution with bulky C-1 and C-3 groups 
substituents only slightly diminished the yield of the desired cycloadduct 20a, 20c, 20d, 
20f, 20l. Reactions of C-3 and C-5 substituted indoles provided good yields of the desired 
product 20b, 20i. However, the reaction of the N-TBS protected skatole provided fair 
yield 20o along with 12% of TBS deprotected 20p cycloadduct, presumably due to the 




Cycloadducts derived from this methodology could serve as building blocks for various 
bioactive imidazoloindoline compounds. Therefore we chose 1,3-dimethylindole 
cycloadduct 69 as a model compound and reduced the two N-O bonds in one pot using 
Mo(CO)6 to afford imidazo[4,5-b]indole 70 in 72% yield. 
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4.6 Experimental 
All reactions were carried out under an atmosphere of nitrogen in oven-dried glassware 
with magnetic stirring, unless otherwise specified. 2,2,3,3-tetrafluoropropan-1-ol was 
purchased from SynQuest and used without further purification. Acetonitrile, 
(diacetoxyiodo)benzene (BAIB or DIB), all other reagents and solvents were purchased 
from Sigma-Aldrich Chemical Company and used without any further purification. Both 
alumina, neutral for column chromatography and alumina N TLC plates’ w/UV254, 
polyester backed, 200µm, 4x8cm for Rf value measurement, were purchased from 
Sorbent Technologies. The TLC plates were developed by staining with KMnO4 or ceric 
ammonium molybdate. Because of the close byproduct, purification of reaction products 
was carried out by flash chromatography using Alumina, neutral or through a medium 
pressure liquid chromatography (MPLC), a Biotage® purification system equipped with 
254 nm and 280 nm UV detectors and by using Biotage zip 80g Si gel column employing 
a hexane, ethyl acetate gradient for the mobile phase. The cartridges for Biotage 
purification system were purchased from Biotage®. 1H-NMR spectra were measured on 
Varian 400 (400 MHz), Varian MR400 (400 MHz), or Varian 500 (500 MHz) 
spectrometers and are reported in ppm (s = singlet, d = doublet, t=triplet, q = quartet, m = 
multiplet, br = broad, dd = doublet of doublets, dt = doublet of triplets and td = triplet of 
doublets; integration; coupling constant(s) in Hz), using TMS as an internal standard 
(TMS at 0.00 ppm) in CDCl3 or the solvent peak (2.54) in (CD3)2SO. 13C-NMR spectra 
were recorded on V400 or V500 spectrometer and reported in ppm using solvent as an 
internal standard (CDCl3 at 77.16 ppm) or (CD3CN at 118.26 ppm). Infrared (IR) spectra 
were recorded on a Nicolet 6700 FT-IR with a diamond ATR and data are reported as cm-
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1 (br = broad, s = strong). High-resolution mass spectra were obtained using an Agilent 
6230 TOF LC/MS with an electrospray (ESI) source with purine and HP-0921 as an 
internal calibrant. The slow additions of urea or (diacetoxyiodo)benzene (BAIB) was 
performed with syringe pump (model: NE-300) purchased from the manufacturer of New 
Era Pump Systems Inc.  
________________________________________________________________________ 
 
1-Propanol, 2,2,3,3-tetrafluoro-, sodium salt  (NaTFP) & N, N'-bis(phenylmethoxy)urea 




General procedure A for the Oxidative Cycloaddition of  Substituted Indoles 17  
 
To a solution of 2,2,3,3-tetrafluoro-1-Propanol (0.25 M with respect to indole) and 1-
Propanol, 2,2,3,3-tetrafluoro-, sodium salt  (TFP-Na) (1.2 equiv.) was added CH3CN 
(1mL), urea 18 (2.0 equiv.), corresponding indole 17 (1.0 equiv) at 0 °C. A solution of 
the (diacetoxyiodo)benzene (DIB) (1.5 equiv.) in anhydrous CH3CN (6.0 mL) was added 
dropwise at 0 °C over a period of 3.0 hours using a syringe pump. The reaction mixture 
was stirred additional 30 minutes at 0 °C, The volatiles were removed under reduced 
pressure and the residue was dissolved in ethyl acetate (50 mL), washed with water (50 
mL) and separated the two layers. The extraction was repeated with water (50 mL) and 
ethyl acetate (2 x 50 mL). The combined organic phase was dried over anhydrous 
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Na2SO4 and concentrated under reduced pressure. The crude product was purified 
through column chromatography using neutral alumina (Al2O3) by employing a hexane, 
ethyl acetate gradient for the mobile phase, except compounds 20g, 20h, which were 






   
 
Prepared via general procedure A in (79 %) yield (116 mg, 0.28 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (192 mg, 0.71 mmol) with 1,3-dimethylindole (51 
mg, 0.35 mmol) as a colorless gummy liquid. Rf = 0.38 (4:1, hexanes: ethyl acetate); 1H 
NMR (500 MHz, CDCl3): δ 7.47 – 7.43 (m, 4H), 7.39 – 7.33 (m, 6H), 7.23 (ddd, J = 7.4, 
1.4, 0.5 Hz, 1H), 7.19 (td, J = 7.7, 1.3 Hz, 1H), 6.72 (td, J = 7.5, 0.9 Hz, 1H), 6.48 (dt, J 
= 7.9, 0.7 Hz, 1H), 5.17 (d, J = 10.2 Hz, 1H), 5.08 (d, J = 10.3 Hz, 1H), 5.03 (d, J = 10.3 
Hz, 1H), 4.97 (d, J = 10.3 Hz, 1H), 4.45 (s, 1H), 2.91 (s, 3H), 1.41 (s, 3H); 13C NMR 
(101 MHz, CDCl3): δ 159.1, 149.8, 135.6, 135.4, 129.9, 129.7, 129.6, 129.1, 128.8, 
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3031, 2929, 2879, 1744, 1607, 1484, 1453, 1427, 1369, 1305, 1266, 1212, 1157, 1117, 
1100, 1043, 1019, 985, 931 cm-1; HR-ESIMS calculated for C25H26N3O3 (M+H)+ 







     
Prepared via general procedure A in (75 %) yield (100 mg, 0.23 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (163 mg, 0.60 mmol) with 1-methyl-3-
isopropylindole (52 mg, 0.30 mmol) as a pale yellow gummy liquid. Rf = 0.40 (4:1, 
hexanes: ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.48 – 7.44 (m, 4H), 7.40 – 7.32 
(m, 6H), 7.21 – 7.20 (m, 1H), 7.18 (dd, J = 7.7, 1.3 Hz, 1H), 6.71 (td, J = 7.5, 1.0 Hz, 
1H), 6.48 (dt, J = 7.9, 1.0 Hz, 1H), 5.19 (d, J = 10.3 Hz, 1H), 5.10 (d, J = 9.9 Hz, 1H), 
5.06 (d, J = 9.9 Hz, 1H), 5.00 (d, J = 10.3 Hz, 1H), 4.61 (s, 1H), 2.91 (s, 3H), 2.46 (app 
septet, J = 6.8 Hz, 1H), 0.98 (d, J = 6.7 Hz, 3H), 0.66 (d, J = 6.9 Hz, 3H); 13C NMR (126 
MHz, CDCl3): δ 159.4, 150.5, 135.6, 135.4, 129.9, 129.7, 129.3, 128.8, 128.6, 128.6, 
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3031, 2961, 2876, 1742, 1606, 1486, 1468, 1453, 1427, 1369, 1302, 1263, 1210, 1156, 








Prepared via general procedure A in (73 %) yield (77 mg, 0.16 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (120 mg, 0.44 mmol) with 1-methyl-5-methoxy-3-
isopropylindole (45 mg, 0.22 mmol) as a pale yellow gummy liquid. Rf = 0.35 (4:1, 
hexanes: ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.47 – 7.44 (m, 4H), 7.40 – 7.31 
(m, 6H), 6.84 (d, J = 2.6 Hz, 1H), 6.76 (dd, J = 8.5, 2.6 Hz, 1H), 6.40 (d, J = 8.5 Hz, 1H), 
5.19 (d, J = 10.3 Hz, 1H), 5.10 (s, 2H), 4.99 (d, J = 10.3 Hz, 1H), 4.57 (s, 1H), 3.67 (s, 
3H), 2.87 (s, 3H), 2.42 (app septet, J = 6.9 Hz, 1H), 0.97 (d, J = 6.7 Hz, 3H), 0.67 (d, J = 
6.9 Hz, 3H); 13C NMR (126 MHz, CDCl3): δ 159.4, 153.2, 144.8, 135.5, 135.4, 129.6, 
129.2, 128.7, 128.6, 128.6, 128.5, 128.4, 114.8, 111.8, 108.3, 81.4, 79.3, 78.5, 73.9, 55.9, 
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1282, 1210, 1178, 1157, 1111, 1019, 910 cm-1; HR-ESIMS calculated for C28H32N3O4 









Prepared via general procedure A in (73 %) yield (90 mg, 0.19 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (137 mg, 0.50 mmol) with 1-methyl-3-
cyclohexylindole (90 mg, 0.42 mmol), (54 mg, 0.25 mmol) as a pale yellow gummy 
liquid. Rf = 0.45 (4:1, hexanes: ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.47 – 7.44 
(m, 4H), 7.39 – 7.31 (m, 6H), 7.20 – 7.16 (m, 2H), 6.70 (td, J = 7.5, 1.0 Hz, 1H), 6.46 (dt, 
J = 7.9, 0.8 Hz, 1H), 5.18 (d, J = 10.4 Hz, 1H), 5.08 (d, J = 10.1 Hz, 1H), 5.01(d, J = 10.1 
Hz, 1H), 4.99 (d, J = 10.4 Hz, 1H), 4.61 (s, 1H), 2.90 (s, 3H), 2.09 – 2.02 (m, 1H), 1.89 – 
1.86 (m, 1H), 1.76 – 1.72  (m, 1H), 1.65 – 1.59 (m, 2H), 1.18 – 1.08 (m, 3H), 1.00 (qt, J 
= 13.1, 3.3Hz, 1H), 0.86 (qd, J = 12.5, 3.6Hz, 1H), 0.74 (qd, J = 12.6, 3.7 Hz, 1H); 13C 
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128.5, 128.5, 127.0, 124.6, 118.5, 107.6, 81.5, 79.2, 78.6, 73.8, 40.3, 33.4, 27.5, 27.3, 
26.3, 26.3, 26.0; IR (film): 3031, 2926, 2852, 1741, 1606, 1486, 1451, 1427, 1366, 1298, 
1262, 1209, 1156, 1106, 1076, 1015, 909 cm-1; HR-ESIMS calculated for C30H34N3O3 







Prepared via general procedure A in (75 %) yield (103 mg, 0.21 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (152 mg, 0.56 mmol) with 3-benzy-1-methyllindole 
(62 mg, 0.28 mmol) as a pale yellow gummy liquid. Rf = 0.35 (4:1, hexanes: ethyl 
acetate); 1H NMR (500 MHz, CDCl3): δ 7.51 – 7.48 (m, 2H), 7.40 – 7.31 (m, 9H), 7.20 – 
7.15 (m, 4H), 6.93 – 6.89 (m, 2H), 6.76 (td, J = 7.5, 1.0 Hz, 1H), 6.38 (dt, J = 8.0, 0.7 Hz, 
1H), 5.20 (d, J = 10.2 Hz, 1H), 5.05 (d, J = 10.2 Hz, 1H), 4.88 (d, J = 10.5 Hz, 1H), 4.80 
(d, J = 10.5 Hz, 1H), 4.59 (s, 1H), 3.26 (d, J = 14.0 Hz, 1H), 3.05 (d, J = 14.0 Hz, 1H), 
2.65 (s, 3H); 13C NMR (126 MHz, CDCl3): δ 158.4, 150.6, 135.6, 135.5, 134.7, 130.1, 
130.1, 129.5, 129.5, 128.7, 128.6, 128.5, 128.3, 127.8, 127.0, 124.6, 118.7, 107.9, 82.9, 
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1305, 1213, 1156, 1098, 1059, 1021, 909 cm-1; HR-ESIMS calculated for C31H30N3O3 









Prepared via general procedure A in (51 %) yield (49 mg, 0.09 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (94 mg, 0.34 mmol) with 1-methyl-3-(t-
butyldimethylsilyl)oxyethylindole (50 mg, 0.17 mmol) as a pale yellow gummy liquid. Rf 
= 0.50 (4:1, hexanes: ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.47 – 7.42 (m, 4H), 
7.40 – 7.32 (m, 6H), 7.21 (ddd, J = 7.4, 1.3, 0.6 Hz, 1H), 7.18 (dd, J = 7.7, 1.3 Hz, 1H), 
6.70 (td, J = 7.4, 0.9 Hz, 1H), 6.47 (dt, J = 7.9, 0.7 Hz, 1H), 5.17 (d, J = 10.2 Hz, 1H), 
5.11 (s, 1H), 5.09 (s, 2H), 4.97 (d, J = 10.3 Hz, 1H), 3.57 (ddd, J = 10.6, 6.8, 5.4 Hz, 1H), 
3.45 (ddd, J = 10.7, 6.4, 5.4 Hz, 1H), 2.90 (s, 3H), 2.07 (ddd, J = 14.7, 6.3, 5.4 Hz, 1H), 
2.02 (ddd, J = 14.7, 6.8, 5.5 Hz, 1H), 0.83 (s, 9H), -0.05 (s, 3H), -0.07 (s, 3H); 13C NMR 
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128.5, 128.5, 127.9, 124.7, 118.6, 107.6, 83.1, 79.5, 78.4, 68.8, 58.5, 36.6, 33.0, 25.9, 
18.1, -5.5, -5.5; IR (film): 3031, 2927, 2855, 1747, 1607, 1485, 1470, 1427, 1454, 1360, 
1308, 1252, 1212, 1156, 1091, 1055, 1023, 909 cm-1; HR-ESIMS calculated for 






Prepared via general procedure A in (70 %) yield (66 mg, 0.11 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (89 mg, 0.33 mmol) with 2-(2-(1-methyl-1H-indol-
3-yl)ethyl)-isoindole-1,3-(2H)dione (50 mg, 0.16 mmol) as a pale yellow solid. Rf = 0.15 
(4:1, hexanes: ethyl acetate); mp = 55.2 – 58.0 °C; 1H NMR (500 MHz, CDCl3): δ 7.80 – 
7.76 (m, 2H), 7.70 – 7.66 (m, 2H), 7.50 – 7.46 (m, 4H), 7.42 – 7.33 (m, 5H), 7.29 – 7.26 
(m, 1H), 7.21 (ddd, J = 7.4, 1.3, 0.6 Hz, 1H), 7.11 (td, J = 7.7, 1.3 Hz, 1H), 6.62 (td, J = 
7.5, 1.0 Hz, 1H), 6.44 (dt, J = 8.0, 0.7 Hz, 1H), 5.21 (d, J = 10.2 Hz, 1H), 5.20 (d, J = 9.9 
Hz, 1H), 5.13 (d, J = 10.0 Hz, 1H), 4.99 (d, J = 10.3 Hz, 1H), 4.85 (s, 1H), 3.71 (ddd, J = 
13.7, 10.3, 5.1 Hz, 1H), 3.48 (ddd, J = 13.8, 10.2, 6.0 Hz, 1H), 2.94 (s, 3H), 2.27 (ddd, J 
= 14.1, 10.3, 6.1 Hz, 1H), 2.19 (ddd, J = 14.0, 10.2, 5.1 Hz, 1H); 13C NMR (126 MHz, 
CDCl3): δ 167.8, 159.1, 149.9, 135.4, 135.3, 133.9, 132.0, 130.1, 129.7, 129.6, 128.8, 
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32.4; IR (film): 3031, 2941, 1747, 1606, 1485, 1444, 1399, 1371, 1308, 1243, 1210, 
1188, 1157, 1116, 1090, 1062, 1022, 983, 910 cm-1; HR-ESIMS calculated for 








Prepared via general procedure A in (74 %) yield (109 mg, 0.23 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (169 mg, 0.62 mmol) with methyl 1-methyl-1H-
indole-3-acetate (63 mg, 0.31 mmol) as a colorless gummy liquid. Rf = 0.25 (4:1, 
hexanes: ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.50 – 7.43 (m, 4H), 7.40 – 7.33 
(m, 6H), 7.22 (ddd, J = 7.4, 1.3, 0.6 Hz, 1H), 7.19 (td, J = 7.7, 1.3 Hz, 1H), 6.69 (td, J = 
7.5, 1.0 Hz, 1H), 6.47 (dd, J = 7.9, 0.8 Hz, 1H), 5.30 (s, 1H), 5.17 (d, J = 10.1 Hz, 1H), 
5.14 (d, J = 10.1 Hz, 1H), 5.09 (d, J = 10.1 Hz, 1H), 4.96 (d, J = 10.1 Hz, 1H), 3.62 (s, 
3H), 2.94 (d, J = 15.4 Hz, 1H), 2.92 (s, 3H), 2.73 (d, J = 15.4 Hz, 1H); 13C NMR (126 
MHz, CDCl3): δ 169.3, 159.3, 149.7, 135.5, 135.2, 130.4, 129.6, 129.5, 128.8, 128.7, 
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(film): 3031, 2949, 1737, 1606, 1485, 1453, 1435, 1353, 1309, 1208, 1156, 1116, 1096, 









Prepared via general procedure A in (65 %) yield (110 mg, 0.25 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (207 mg, 0.76 mmol) with 1-methy-indole-3-
acetonitrile (65 mg, 0.38 mmol) as a white solid. Rf = 0.13 (4:1, hexanes: ethyl acetate); 
mp = 48.5 – 51.6 °C; 1H NMR (400 MHz, CDCl3): δ 7.53 – 7.49 (m, 2H), 7.43 – 7.38 (m, 
5H), 7.38 – 7.34 (m, 3H), 7.28 (ddd, J = 7.5, 1.3, 0.6 Hz, 1H), 7.23 (td, J = 7.8, 1.3 Hz, 
1H), 6.73 (td, J = 7.5, 0.9 Hz, 1H), 6.48 (dt, J = 8.0, 0.7 Hz, 1H), 5.22 (d, J = 10.8 Hz, 
1H), 5.16 (d, J = 10.1 Hz, 1H), 5.14 (d, J = 10.8 Hz, 1H), 4.94 (d, J = 10.2 Hz, 1H), 4.77 
(s, 1H), 2.89 (s, 3H), 2.61 (d, J = 17.2 Hz, 1H), 2.53 (d, J = 17.2 Hz, 1H); 13C NMR (101 
MHz, CDCl3): δ 159.0, 149.3, 135.4, 134.8, 131.2, 129.9, 129.7, 129.1, 129.0, 128.8, 
128.7, 125.3, 124.9, 119.3, 115.4, 108.3, 83.0, 79.9, 78.7, 66.7, 32.5, 24.6; IR (film): 
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Prepared via general procedure A in (81 %) yield (97 mg, 0.20 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (133 mg, 0.49 mmol) with 5-bromo-1,3-
dimethylindole (55 mg, 0.24 mmol) as a white solid. Rf = 0.4 (4:1, hexanes: ethyl 
acetate); mp = 133.3 – 136.3 °C; 1H NMR (500 MHz, CDCl3): δ 7.46 – 7.41 (m, 4H), 
7.40 – 7.32 (m, 6H), 7.28 – 7.25 (m, 2H), 6.33 (d, J = 8.1 Hz, 1H), 5.17 (d, J = 10.3 Hz, 
1H), 5.09 (d, J = 10.7 Hz, 1H), 5.05 (d, J = 10.7 Hz, 1H), 4.96 (d, J = 10.3 Hz, 1H), 4.41 
(s, 1H), 2.86 (s, 3H), 1.31 (s, 3H); 13C NMR (126 MHz, CDCl3): δ 159.1, 148.7, 135.4, 
135.2, 132.5, 131.2, 129.8, 129.7, 128.9, 128.8, 128.6, 128.5, 127.3, 110.6, 109.2, 85.8, 
79.8, 78.6, 66.2, 33.1, 21.2; IR (film): 2883, 1725, 1602, 1484, 1457, 1428, 1420, 1391, 
1372, 1356, 1312, 1285, 1261, 1213, 1188, 1133, 1114, 1065, 1042, 1014, 1003, 990, 
954, 929, 920, 909 cm-1; HR-ESIMS calculated for C25H25BrN3O3 (M+H)+ 494.10738; 

















Prepared via general procedure A in (67 %) yield (67 mg, 0.12 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (96 mg, 0.35 mmol) with 1-benzyl-5-bromo-3-
methylindole (53 mg, 0.18 mmol) as a colorless solid. Rf = 0.40 (4:1, hexanes: ethyl 
acetate); mp = 43.5 – 46.4 °C; 1H NMR (500 MHz, CDCl3): δ 7.48 – 7.45 (m, 2H), 7.40 – 
7.33 (m, 8H), 7.31 – 7.25 (m, 4H), 7.19 – 7.18 (m, 2H), 7.16 (dd, J = 8.4, 2.1 Hz, 1H), 
6.17 (d, J = 8.4 Hz, 1H), 5.12 (d, J = 10.6 Hz, 1H), 5.10 (s, 2H), 4.99 (d, J = 10.6 Hz, 
1H), 4.56 (s, 1H), 4.28 (d, J = 15.8 Hz, 1H), 4.20 (d, J = 15.8 Hz, 1H), 1.29 (s, 3H); 13C 
NMR (126 MHz, CDCl3): δ 159.0, 147.7, 137.0, 135.5, 135.3, 132.4, 131.4, 129.9, 129.9, 
128.9, 128.9, 128.7, 128.6, 128.5, 127.6, 127.5, 127.1, 110.7, 109.7, 84.1, 79.8, 78.5, 
66.4, 49.8, 21.5; IR (film): 3030, 2926, 1746, 1600, 1480, 1417, 1349, 1263, 1165, 1130, 
1074, 1044, 1027, 967, 920 cm-1; HR-ESIMS calculated for C31H28BrN3NaO3 (M+Na)+ 


















Prepared via general procedure A in (66 %) yield (81 mg, 0.16 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (135 mg, 0.50 mmol) with 1-benzyl-3-methylindole 
(55 mg, 0.25 mmol) as a colorless gummy liquid. Rf = 0.33 (4:1, hexanes: ethyl acetate); 
1H NMR (400 MHz, CDCl3): δ 7.48 – 7.45 (m, 2H), 7.41 – 7.31 (m, 8H), 7.30 – 7.23 (m, 
6H), 7.09 (td, J = 7.7, 1.3 Hz, 1H), 6.71 (td, J = 7.5, 0.9 Hz, 1H), 6.34 (dt, J = 7.9, 0.8 
Hz, 1H), 5.14 (d, J = 10.5 Hz, 1H), 5.09 (s, 2H), 4.98 (d, J = 10.5 Hz, 1H), 4.60 (s, 1H), 
4.34 (s, 2H), 1.40 (s, 3H); 13C NMR (126 MHz, CDCl3): δ 159.2, 148.9, 137.6, 135.6, 
135.4, 129.8, 129.8, 129.7, 129.3, 128.8, 128.8, 128.7, 128.6, 128.5, 127.4, 127.2, 124.5, 
119.0, 108.3, 84.2, 79.9, 78.5, 66.8, 50.1, 21.7; IR (film): 3030, 2927, 1745, 1606, 1482, 
1465, 1452, 1350, 1317, 1265, 1212, 1166, 1122, 1101, 1043, 1027, 966, 908 cm-1; HR-
















Prepared via general procedure A in (60 %) yield (58 mg, 0.10 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (94 mg, 0.35 mmol) with 1-benzyl-3-
cyclohexylindole (50 mg, 0.17 mmol) as a pale yellow gummy liquid. Rf = 0.48 (4:1, 
hexanes: ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.46 – 7.44 (m, 2H), 7.39 – 7.30 
(m, 10H), 7.28 – 7.21 (m, 4H), 7.09 (td, J = 7.7, 1.3 Hz, 1H), 6.71 (td, J = 7.5, 1.0 Hz, 
1H), 6.36 (d, J = 7.9 Hz, 1H), 5.14 (d, J = 10.5 Hz, 1H), 5.09 (d, J = 10.3 Hz, 1H), 5.02 
(d, J = 10.1 Hz, 1H), 4.96 (d, J = 10.5 Hz, 1H), 4.80 (s, 1H), 4.46 (d, J = 16.0 Hz, 1H), 
4.41 (d, J = 16.0 Hz, 1H), 2.10 – 2.04 (m, 1H), 1.89 – 1.83 (m, 1H), 1.74 – 1.69 (m, 1H), 
1.63 – 1.59 (m, 2H), 1.22 – 1.05 (m, 3H), 0.96 (qt, J = 13.4, 3.7 Hz, 1H), 0.79 (qd, J = 
12.6, 3.6 Hz, 1H), 0.69 (qd, J = 12.7, 3.4 Hz, 1H); 13C NMR (126 MHz, CDCl3): δ 159.3, 
150.1, 137.5, 135.6, 135.5, 129.8, 129.7, 129.3, 128.7, 128.6, 128.6, 128.5, 128.5, 127.3, 
127.3, 127.0, 124.7, 118.6, 108.1, 79.9, 79.2, 78.4, 73.9, 50.6, 40.3, 27.5, 27.4, 26.3, 26.3, 
25.9; IR (film): 3030, 2926, 2851, 1742, 1604, 1483, 1464, 1451, 1353, 1309, 1263, 
1212, 1159, 1125, 1080, 1001, 909 cm-1; HR-ESIMS calculated for C36H38N3O3 (M+H)+ 















Prepared via general procedure A in (85 %) yield (138 mg, 0.32 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (205 mg, 0.75 mmol) with 1-ethyl-3-methylindole 
(60 mg, 0.38 mmol) as a pale yellow gummy liquid. Rf = 0.35 (4:1, hexanes: ethyl 
acetate); 1H NMR (500 MHz, CDCl3): δ 7.47 – 7.42 (m, 4H), 7.39 – 7.32 (m, 6H), 7.24 
((ddd, J = 7.4, 1.4, 0.6 Hz, 1H, 1H), 7.16 (td, J = 7.7, 1.3 Hz, 1H), 6.69 (td, J = 7.5, 1.0 
Hz, 1H), 6.48 (dt, J = 8.0, 0.8 Hz, 1H), 5.15 (d, J = 10.3 Hz, 1H), 5.08 (d, J = 10.4 Hz, 
1H), 5.03 (d, J = 10.4 Hz, 1H), 4.95 (d, J = 10.3 Hz, 1H), 4.57 (s, 1H), 3.35 – 3.19 (m, 
2H), 1.39 (s, 3H), 1.19 (t, J = 7.2 Hz, 3H); 13C NMR (126 MHz, CDCl3): δ 159.1, 148.9, 
135.7, 135.4, 129.8, 129.7, 129.6, 129.4, 128.8, 128.7, 128.6, 128.5, 124.4, 118.7, 107.8, 
83.3, 79.9, 78.7, 66.7, 40.5, 21.5, 12.4; IR (film): 3031, 2972, 2878, 1744, 1606, 1483, 
1453, 1368, 1318, 1290, 1265, 1210, 1180, 1157, 1120, 1102, 1044, 1029, 993, 931 cm-1; 

















Prepared via general procedure A in (78 %) yield (109 mg, 0.25 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (171 mg, 0.63 mmol) with 1-allyl-3-methylindole 
(54 mg, 0.32 mmol) as a pale yellow gummy liquid. Rf = 0.35 (4:1, hexanes: ethyl 
acetate); 1H NMR (500 MHz, CDCl3): δ 7.46 – 7.42 (m, 4H), 7.39 – 7.32 (m, 6H), 7.24 
(ddd, J = 7.4, 1.3, 0.5, Hz, 1H), 7.15 (td, J = 7.7, 1.3 Hz, 1H), 6.71 (td, J = 7.5, 0.9 Hz, 
1H), 6.49 (dt, J = 7.9, 0.7 Hz, 1H), 5.80 (dddd, J = 17.2, 10.2, 5.9, 5.2 Hz, 1H), 5.22 – 
5.15 (m, 2H), 5.14 (d, J = 10.4 Hz, 1H), 5.07 (d, J = 10.3 Hz, 1H), 5.0 (d, J = 10.4 Hz, 
1H), 4.99 (d, J = 10.4 Hz, 1H), 4.59 (s, 1H), 3.84 – 3.81 (m, 2H), 1.41 (s, 3H); 13C NMR 
(126 MHz, CDCl3): δ 158.9, 148.9, 135.6, 135.4, 133.2, 129.8, 129.8, 129.7, 129.3, 
128.8, 128.7, 128.6, 128.5, 124.3, 118.9, 117.5, 108.4, 83.7, 79.9, 78.6, 66.9, 49.0, 21.3; 
IR (film): 3031, 2928, 1745, 1607, 1482, 1465, 1453, 1418, 1369, 1307, 1264, 1212, 
1170, 1121, 1099, 1080, 1043, 1025, 989, 910 cm-1; HR-ESIMS calculated for 















Prepared via general procedure A in (33 %) yield (40 mg, 0.08 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (126 mg, 0.46 mmol) with 1-(t-butyldimethylsilyl)-
3-methylindole (57 mg, 0.23 mmol) as a colorless gummy liquid. Rf = 0.53 (4:1, hexanes: 
ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.53 – 7.51 (m, 2H), 7.43 – 7.40 (m, 3H), 
7.39 –7.31 (m, 6H), 7.10 (td, J = 7.6, 1.6 Hz, 1H), 6.83 (dt, J = 8.1, 0.8 Hz, 1H), 6.75 (td, 
J = 7.5, 1.0 Hz, 1H), 5.27 (d, J = 10.7 Hz, 1H), 5.16 (d, J = 9.7 Hz, 1H), 5.08 (d, J = 10.7 
Hz, 1H), 4.88 (d, J = 9.7 Hz, 1H), 4.81 (s, 1H), 1.30 (s, 3H), 0.89 (s, 9H), 0.50 (s, 3H), 
0.34 (s, 3H); 13C NMR (126 MHz, CDCl3): δ 159.0, 149.2, 136.1, 135.0, 132.6, 129.8, 
129.3, 129.0, 128.7, 128.6, 128.4, 125.6, 120.0, 113.1, 82.7, 79.8, 79.6, 68.6, 27.1, 22.9, 
20.4, -2.8, -4.0; IR (film): 3032, 2927, 2882, 2855, 1748, 1601, 1497, 1471, 1460, 1362, 
1333, 1293, 1255, 1210, 1157, 1128, 1095, 1067, 1041, 1025, 979, 910 cm-1; HR-ESIMS 
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(±)-(3aS,8bS)-1,3-di(phenylmethoxy)-8b-methyl-3,3a,4,8b-tetrahydroimidazo[4,5-




Prepared via general procedure A in (12 %) yield (12 mg, 0.03 mmol) from the reaction 
of N, N'-bis(phenylmethoxy)urea 18 (126 mg, 0.46 mmol) with 1-(t-butyldimethylsilyl)-
3-methylindole (57 mg, 0.23 mmol) as a colorless gummy liquid. Rf = 0.18 (4:1, hexanes: 
ethyl acetate); 1H NMR (500 MHz, CDCl3): δ 7.51 – 7.48 (m, 2H), 7.47 – 7.35 (m, 8H), 
7.25 – 7.23 (m, 1H), 7.04 (td, J = 7.7, 1.3 Hz, 1H), 6.70 (td, J = 7.5, 1.0 Hz, 1H), 6.20 (dt, 
J = 7.9, 0.8 Hz, 1H), 5.21 (d, J = 10.5 Hz, 1H), 5.09 (d, J = 10.5 Hz, 1H), 5.03 (d, J = 
12.1 Hz, 1H), 4.88 (d, J = 12.1 Hz, 1H), 4.46 (br s, 1H), 3.01 (s, 1H), 1.30 (s, 3H); 13C 
NMR (126 MHz, CDCl3): δ 159.5, 147.4, 137.4, 135.7, 130.1, 129.7, 129.3, 128.9, 128.9, 
128.8, 128.7, 128.5, 124.9, 119.8, 110.9, 80.5, 79.8, 78.5, 67.0, 22.4; IR (film): 3372, 
3031, 2928, 1733, 1610, 1481, 1468, 1453, 1371, 1313, 1289, 1266, 1212, 1180, 1141, 



















To a solution of 1,3-dimethyl indole cycloadduct 69 (0.255 g, 0.613 mmol) in 
CH3CN/H2O (4 mL, 9:1, degassed under nitrogen) was added Mo(CO)6 (0.388 g, 1.469 
mmol) and again degased under nitrogen. The reaction mixture was vigorously stirred 
and heated to reflux for 6 hours under nitrogen. The complete consumption of 1,3-
dimethyl indole cycloadduct 69 was confirmed by TLC (3:2, hexanes: ethyl acetate). The 
crude reaction mixture was filtered through a celite bed and washed the celite bed with 
ethyl acetate (100 mL). The collected filtrates were combined and concentrated by rotary 
vapor. The crude product was purified by flash column chromatography (9:1, 
dichloromethane: methanol) to afford product 70 as a white solid (91 mg, 0.44 mmol, 
72%). Rf = 0.25 (9.5:0.5, dichloromethane: methanol); mp = 157-159°C; 1H NMR (500 
MHz, CD3OD): δ 7.13 - 7.12 (m, 1H), 7.10 (dd, J = 7.7, 1.3 Hz, 1H), 6.67 (td, J = 7.4, 0.9 
Hz, 1H), 6.47 (dt, J = 7.9, 0.7 Hz, 1H), 4.88 (s, 1H), 4.85 (br s, 2H), 2.82 (s, 3H), 1.56 (s, 
3H); 13C NMR (126 MHz, CD3OD) δ 163.1, 149.9, 132.0, 129.0, 122.2, 117.7, 106.7, 
83.8, 64.6 30.6, 23.8; IR (film): 3216, 2923, 2392, 1608, 1608, 1490, 1445, 1374, 1285, 
1201, 1155, 1117, 1106, 1057, 1018, 990 cm-1; HR-ESIMS calculated for C11H14N3O3 
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Chapter 5: Synthesis of Natural Products and Exploring Ecologically Relevant 







              Natural Products (NPs) are the chemical substances produced by living system 
such as plants, animals and microbes. Secondary metabolites are organism specific 
compounds that serve extremely important ecological functions for organisms.1 For 
example, some plants produce toxic chemical substances to defend them selves from 
herbivores and pathogens. On the other hand, certain species of vertebrates and plants 
produce volatile chemicals to attract or communicate with other species, called 
allelochemicals. Similarly color agents are produced to attract or warn other species. 
Although the function and benefit of majority of the secondary metabolites to the 
producer organism is not comprehensively known yet, it is logical to assume that these 
compounds are produced in nature must be of some benefit to the producer organism.  
              Plants have been successful defending themselves against diverse herbivores and 
various pathogens (e.g., bacteria, virus) by using mixtures of secondary metabolites.2-5  It 
is hypothesized that defensive mixtures often result in synergistic effects against these 
natural enemies and this theory has been receiving growing support from chemical 
ecologists.2-5 One of the long-standing and underexplored questions in chemical ecology 
focuses on why plants have not evolved to produce a single compound of absolute 
potency to defend themselves from insects or pathogens. The Jeffrey group and 
collaborators postulate that synergy could be the reason for the so-called redundancy of 
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phytochemical defense that use multiple modes of action to defend against multiple 
enemies including herbivores and diverse plant pathogens. In contrast to that, humans 
have not been as successful controlling the crop pests using single potent active 
ingredient even at high concentration and high acute toxicity. Therefore the better 
understanding of synergy with biologically active mixtures in the plant defensive 
mechanism has greater applications in the design and development of new agrochemicals 
for the integrated pest management as well as developing new medicines for the 
treatment of various diseases. 
 
             Our collaborative phytochemical studies in chemical ecology have led to the 
isolation of four natural products aegeline (octopamine amide), cinnamide, β-sitosterol 
and stigmasterol from Manekia obtussa (Piperacae), a tropical vine that grows in the 
forests of Brazil. The mixtures of isolated phytochemicals 21, 22, 23, 24 (Figure 1.4.1) 
have demonstrated significant synergistic activity against generalist (Spodoptera exigua) 
herbivore at their natural concentration by reducing the survival and pupal mass only 
when administered as a mixture. Inspired by the results we asked more general questions 
that 1) How did plants evolve to produce highly diverse of secondary metabolites? 2) 
Why is the same class of compounds found across distantly related plant families? 3) 
What happens if we add an unnatural analogue to the natural mixture, will that affect the 
synergy of defensive chemistry? To answer these questions we decided to test the 
hypotheses by developing a library of natural and unnatural compound mixtures and test 
these in a variety of ecologically relevant bioassays. However this proposal constrained 
due to the limited commercial availability of natural products and their unnatural 
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analogues. Therefore we have developed a modified scalable enantioselective synthesis 
of octopamine amide analogues and other co-occurring sterols. This synthetic route also 
provided access to a gram scale synthesis of octopamine, p-hydroxyethanolamine, which 
we recently discovered in the floral nectar of citrus plants.  
 
 




              Octopamine was first discovered15,16 in the salivary glands of octopus vulgaris, is 
an endogenous biogenic amine and found in both is found in both vertebrate and 
invertebrate nervous systems. In insects’ nervous systems octopamine plays an important 























Native: R1 = Ph or cinnamyl
R1 = various substitued 
cinnamyl and phenyl groups 
R2 = H, OH, OCH3, OAc
R3 = H, OMe, NO2, CO2H, CF3
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neuromodulator, and neurohormone. A scalable enantioselective synthesis of octopamine 
and its analogs would provide access to the necessary material to fully study the 
ecological relevance and biological activity of this widespread class of natural product. 
 
 
5.2 A Scalable and Enantioselective Synthesis of Octopamine and its Analogs 
 
 
Scheme 5.2.1. Enantioselective synthesis of aegeline analogue 75 
 
         In order to understand the ecologically relevant biological activities of the 
octopamine, and its analogues hundred milligram quantities of each of the analogs will be 
required to perform the comprehensive bioassays. Several reports have described for the 
enantioselective synthesis of octopamine and its derivatives.6-14 Our intial attempts were 
made towards the synthesis of aegeline analogue 78a using repoted method by Kumar et 
al.6 and the synthesis was intiated with commercially available 4-methoxystyrene. 
Asymmetric dihyroxylation of the styrene using AD-mix-α, [(DHQD)2PHAL as a 
ligand] gave the diol 96%. However, tosylation of the primary alcohol provided the 
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formation of undesired epoxide in the reaction, rendered the yields for the desired 
tosylated product, moreover tedious column chromatography was necessary to separate 
the desired product. Therefore we decided to persue an alternative strategy for the 
synthesis of enantiopure (R or S) β-hydroxyphenethylamines from functionalized 
acetophenones13 (scheme 5.2.1). This route has produced gram quantities of both 
antipodes of enantiopure octopamine and its analogs.  
 
             
 
          Scheme 5.2.2. General enantioselective synthetic route for the amino alcohols 
 
              Our modified synthesis was initiated with simple and commercially available 
para-hydroxy acetophenone and protected the alcohol with benzyl 76b for octopamine 
synthesis. In case of aegeline and its analogs we begin the synthesis with para-methoxy 
acetophenone 76a. The starting ketones 76a, 76b were subjected to α-tosyloxylation with 






76a: R 1 = CH3
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77a: R 1 = CH3
77b: R1 = Bn
78a: R 1 = CH3
78b: R1 = Bn
79a: R 1 = CH3
79b: R1 = Bn 80a: R 1 = CH3
80b: R1 = Bn
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corresponding α-tosyloxy acetophenones 77a, 77b.  Asymmetric transfer hydrogenation 
of functionalized aromatic ketones 77a, 77b with RuCl[(R,R)]-TsDPEN or RuCl[(S,S)]-
TsDPEN catalyst and in azeotropic mixtures of formic acid/triethylamine as hydrogen 
donors, furnished the enantiopure alcohols 78a, 78b. Treating the tosyloxy carbinol 
intermediates 78a, 78b with sodium azide provided the azides 79a, 79b, which were then 
reduced under hydrogen (1 atm) over 10% Pd/C in MeOH to the corresponding desired 




Scheme 5.2.2. Deprotection of benzyl group for the octopamine synthesis 
 
              The enantiopure amino alcohol 80b was further subjected to hydrogenation with 
hydrogen over 10% Pd/C in AcOH to obtain R or S octopamine as acetic acid salts 81. 
The carbinol intermediate 80a was acylated the amine with acyl chlorides 82 to obtain 
aegeline and its derivatives 83. The required acyl chlorides either prepared from 
corresponding acids by treating with oxalyl chloride in dichloromethane or purchased 
from commercial supplier (Aldrich). All the acid chlorides reacted very well and 
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aThe acid chlorides were added slowly drop wise for 2h in dichloromethane at 0 °C to a mixture 
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5.3 Preliminary Results 
 
5.3.1. Synergistic mixtures of natural products and their anti-herbivore properties          
Many mixtures of plant secondary metabolites are the result of late-stage 
functionalization (e.g., oxidation, reduction, methylation). In order to clarify the effect 
that single structural modifications have on the synergistic activity of the mixture, we 
pursued enantioselective synthesis of aegeline and its analogs and other isolated co-
occurring sterols and cinnamide and evaluated the biological activity. The sitostenone-
only diet reduced the survival of individuals for the generalist (Spodoptera) herbivore; 
however, this effect was ameliorated when mixed with sterols. Indeed, the full mixture 
(sterols, cinnamide and aegleline) acted synergistically to enhance the toxicity to 
individuals. On the other hand, an enantiomeric analog of aegeline enhanced the survival 
of the generalist caterpillar; however, when evaluated as a mixture with cinnamide, it has 
the opposite effect, resulting in increased toxicity.    
 
5.3.2. Aegeline analogs as selective inhibitors of N-acyltransferase 
N-acyltransferases, provide phenethylamides that known to function to repair plant cell 
walls during damage and development.  Selective and potent inhibitors of octopamine N-
acyltranferase in this development are sought to better understand the role of this enzyme 
in plant cell wall development. Our synthetic amides comprise un-natural analogs of 
aegeline and could serve as isosteric molecules that demonstrate inhibitory activity 
against N-transferases, thereby affecting the plants growth a development.  Preliminary 
screening of our synthetic analogs in a root growth assay using Arabodopsis Thaliana (a 
model organism for studying plant cell wall development) revealed that the R-78e analog 
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as a potent inhibitor of root growth.  Interestingly, the enantiomer of this compound also 






All reactions were carried out under an atmosphere of nitrogen in oven-dried glassware 
with magnetic stirring, unless otherwise specified. Dichloromethane was purified by 
passage through a bed of activated alumina. The 4-hydroxyacetophenone, 4-
methoxyacetophenone and all other reagents and solvents were purchased from Sigma-
Aldrich Chemical Company and used without any further purification. TLC information 
was recorded on Silicycle glass 60 F254 plates and developed by staining with KMNO4 or 
ceric ammonium molybdate. Purification of reaction products was carried out by flash 
chromatography using Silicycle Siliaflash® P60 (230-400 mesh). 1H-NMR spectra were 
measured on Varian 400 (400 MHz), Varian MR400 (400 MHz), or Varian 500 (500 
MHz) spectrometers and are reported in ppm (s=singlet, d=doublet, t=triplet, q=quartet, 
m=multiplet, br=broad; integration; coupling constant(s) in Hz), using TMS as an internal 
standard (TMS at 0.00 ppm) in CDCl3 or the solvent peak (2.54) in (CD3)2SO. 13C-NMR 
spectra were recorded on V400 or V500 spectrometer and reported in ppm using solvent 
as an internal standard (CDCl3 at 77.16 ppm) or (CD3CN at 118.26 ppm). Infrared (IR) 
spectra were recorded on a Nicolet 6700 FT-IR with a diamond ATR and data are 
reported as cm-1 (br = broad, s = strong). High-resolution mass spectra were obtained 
using an Agilent 6230 TOF LC/MS with an (atmospheric pressure photo-ionization 
	   127	  









To a solution of corresponding acid (1.0 equv.) in dry CH2Cl2 (150 mL), was added 
dropwise oxalyl chloride (1.5 equv.) at 0 °C along with catalytic amount of DMF (1 drop) 
and vigorously stirred for 2 h at room temperature. The complete consumption of acid 
was monitored by TLC. The solvents were evaporated with rotary vapor and diluted with 
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To a solution of octopamine 80a (0.5 g, 2.46 mmol, 1.0 equv.) in dry CH2Cl2 (20 mL), 
was added pyridine (10 mL) at 0 °C and the mixture was vigorously stirred for 10 min. 
To the above mixture was added a solution of acid chloride (1.05 equv.) 82 in dry CH2Cl2 
(30 mL) dropwise for 2 h, at 0 °C and then the reaction mixture was vigorously stirred for 
additional 16 h at room temperature. The reaction mixture was diluted with and water (50 
mL) and extracted additional CH2Cl2 (50 mL). The organic layer was separated and 
washed with saturated solution of NaHCO3 (25 mL) followed by brine (30 mL) and water 
(30 mL). The organic layer collected, dried with Na2SO4 and evaporated with rotary 
vapor. The crude product was recrystallized from ethanol/water (v/v = 80:20) to obtain 




Prepared via general procedure B in (60 %) yield (A = 890 mg, 2.99 mmol) from the 
reaction of  (S )-(+)-2-Amino-1-(p -methoxyphenyl)ethanol hydrochloride 75a (1000 mg, 
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white solid. Rf = 0.47 (9.5:0.5, dichloromethane: methanol); mp 193.8-194.6 ºC; 1H 
NMR (500 MHz, (CD3)2SO): δ 8.13 (t, J = 5.8, 1H), 7.56 - 7.53 (m, 2H), 7.43 – 7.41 (m, 
2H), 7.40 - 7.35 (m, 2H), 7.29 – 7.26 (m, 2H), 6.90 (d, J = 8.7, 2H), 6.73 (d, J = 15.8, 
1H), 5.43 (d, J = 4.4, 1H), 4.63 – 4.60 (m, 1H), 3.73 (s, 3H), 3.43 – 3.38 (m, 1H), 3.25 – 
3.20 (m, 1H); 13C NMR (126 MHz, (CD3)2SO): δ 165.1, 158.4, 138.5, 135.7, 135.0, 
129.4, 128.9, 127.5, 127.2, 122.4, 113.4, 70.9, 55.0, 47.0; IR (film) 3358, 3280, 3084, 
3016, 2961, 2934, 2897, 2834, 1969, 1910, 1648, 1657, 1557, 1510, 1451, 1438, 1420, 
1341, 1305, 1276, 1246, 1227, 1175, 1113, 1074, 1048, 1033, 991, 961, 944 cm-1; HRMS 





Prepared via general procedure B in (43 %) yield (A = 360 mg, 1.05 mmol) from the 
reaction of (S )-(+)-2-Amino-1-(p -methoxyphenyl)ethanol hydrochloride 75a (500 mg, 
2.46 mmol) with 4-methoxycinnamoyl chloride  (A = 506 mg, 2.58 mmol) and pyridine 
(10 mL) as a white solid. Rf = 0.45 (9.5:0.5, dichloromethane: methanol); mp 186 – 188 
°C; 1H NMR (500 MHz, (CD3)2SO): δ 8.03 (t, J = 5.8 Hz, 1H), 7.49 (d, J = 8.7 Hz, 2H), 
7.35 (d, J = 15.8 Hz, 1H), 7.27 (d, J = 8.4, 2H), 6.97 (d, J = 8.8, 2H), 6.89 (d, J = 8.8, 
2H), 6.57 (d, J = 15.8, 1H), 5.43 (d, J = 4.4, 1H), 4.62 – 4.59 (1m, IH), 3.78 (s, 3H), 3.73 
(3H, s), 3.42 – 3.37 (m, 1H), 3.24 - 3.19 (m, 1H); 13C NMR (126 MHz, (CD3)2SO): δ 
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55.0, 47.0; IR (film) 3256, 2931, 2836, 2037, 1659, 1600, 1575, 1542, 1509, 1462, 1421, 
1352, 1303, 1285, 1231, 1172, 1114, 1067, 1027, 981, 963, 896 cm-1; HRMS calculated 






Prepared via general procedure B in (47 %) yield (A = 420 mg, 1.23 mmol) from the 
reaction of (S )-(+)-2-Amino-1-(p -methoxyphenyl)ethanol hydrochloride 75a (500 mg, 
2.46 mmol) with 3,4-(methylenedioxy)cinnamoyl chloride  (A = 568 mg, 2.58 mmol) and 
pyridine (10 mL) as a off-white solid. Rf = 0.43 (9.5:0.5, dichloromethane: methanol); 
mp 168.3 – 169.6 °C; 1H NMR (500 MHz, (CD3)2SO): δ 7.99 (t, J = 5.8 Hz, 1H), 7.32 (d, 
J = 15.7 Hz, 1H), 7.27 (, d, J = 8.6 Hz, 2H), 7.12 (d, J = 1.3, 1H), 7.05 (dd, J = 8.1, 1.4, 
Hz, 1H), 6.94 (d, J = 8.0, 1H), 6.89 (d, J = 8.6, 2H) 6.56 (d, J = 15.7 Hz, 1H), 6.06 (s, 
2H), 5.43 (d, J = 4.4, 1H), 4.62 – 4.59 (m, 1H), 3.73 (s, 3H), 3.42 - 3.37 (m, 1H, ), 3.24 – 
3.19 (m, 1H); 13C NMR (126 MHz, (CD3)2SO): δ 165.3, 158.3, 148.4, 147.9, 138.3, 
135.7, 129.3, 127.1, 123.1, 120.4, 113.4, 108.6, 106.1, 101.4, 71.0, 55.0, 47.0; IR (film) 
3209, 2887, 1663, 1513, 1628, 1611, 1568, 1513, 1501, 1489, 1437, 1360, 1239, 1178, 
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Prepared via general procedure B in (42 %) yield (A = 384 mg, 1.05 mmol) from the 
reaction of (S )-(+)-2-Amino-1-(p -methoxyphenyl)ethanol hydrochloride 75a (500 mg, 
2.46 mmol) with 4-(trifluoromethyl)cinnamoyl chloride  (A = 604 mg, 2.58 mmol) and 
pyridine (10 mL) as a white solid. Rf = 0.43 (9.5:0.5, dichloromethane: methanol); mp 
217.2 – 219.6 °C; 1H NMR (500 MHz, (CD3)2SO): δ 8.24 (t, J = 5.8 Hz, 1H), 7.76 (s, 
4H), 7.49 (d, J = 15.8 Hz, 1H), 7.28 (d, J = 8.6 Hz, 2H), 6.91 – 6.86 (m, 3H), 5.46 (d, J = 
4.4 Hz, 1H ), 4.65 – 4.62 (m, 1H), 3.73 (s, 3H), 3.46 – 3.41 (m, 1H), 3.28 – 3.23 (m, 1H); 
IR (film) 3269, 3085, 2934, 2842, 1662, 1623, 1613, 1570, 1512, 1461, 1416, 1320, 
1246, 1204, 1166, 1125, 1110, 1059, 1031, 1012, 983, 957, 929; 13C NMR (101 MHz, 
(CD3)2SO): δ 164.6, 158.4, 139.1, 136.9, 135.7, 129.1 (q, J = 31.8), 128.1, 127.2, 125.8 
(q, J = 3.8), 125.2, 122.8, 113.4, 70.9, 55.0, 47.1; HRMS calculated for C19H18F3NO3 










Prepared via general procedure B in (56 %) yield (A = 510 mg, 1.39 mmol) from the 
reaction of (S )-(+)-2-Amino-1-(p -methoxyphenyl)ethanol hydrochloride 75a (A = 500 
mg, 2.46 mmol) with 3-(trifluoromethyl)cinnamoyl chloride (604 mg, 2.58 mmol) and 
pyridine (10 mL) as a white solid. Rf = 0.45 (9.5:0.5, dichloromethane: methanol); mp 
168.3 – 169.6 °C; 1H NMR (500 MHz, (CD3)2SO): δ 8.13 (t, J = 5.7 Hz, IH), 7.90 (s, 
1H), 7.86 (d, J = 7.8 Hz, 1H), 7.72 (d, J = 7.7 Hz, 1H), 7.65 (t, J = 7.8, 1H), 7.49 (d, J = 
15.8 Hz, 1H), 7.28 (d, J = 8.5 Hz, 2H), 6.90 (d, J = 8.7, 2H), 6.88 ( d, J = 15.9, 1H), 5.44 
(d, J = 4.3, 1H), 4.63 – 4.60 (m, 1H), 3.73 (s, 3H), 3.44 – 3.39 (m, 1H), 3.27 – 3.22 (m, 
1H); 13C NMR (126 MHz, (CD3)2SO): δ 164.6, 158.4, 136.8, 136.2, 135.6, 131.3, 130.0, 
129.8, 129.6, 127.2, 125.6 (q, J = 3.7), 125.1, 124.5, 123.7 (q, J = 3.9), 122.9, 113.4, 
70.9, 55.0, 47.0; IR (film) 3361, 3280, 3088, 2937, 2833, 1652, 1595, 1564, 1511, 1458, 
1440, 1332, 1305, 1250, 1225, 1197, 1170, 1138, 1125, 1096, 1070, 1049, 1037, 991, 













Prepared via general procedure B in (53 %) yield (A = 355 mg, 1.30 mmol) from the 
reaction of (S )-(+)-2-Amino-1-(p -methoxyphenyl)ethanol hydrochloride 75a (500 mg, 
2.46 mmol) with benzoyl chloride  (A = 0.300 mL, 2.58 mmol) and pyridine (10 mL) as a 
white solid. Rf = 0.45 (9.5:0.5, dichloromethane: methanol); mp 144.5 – 146 ºC; 1H NMR 
(500 MHz, (CD3)2SO) δ 8.46 (t, J = 5.7 Hz, 1H), 7.84 – 7.82 (m, 2H), 7.53 – 7.49 (m, 
1H), 7.47 – 7.43 (m, 2H), 7.28 (d, J = 8.6 Hz, 2H), 6.89 (d, J = 8.7 Hz, 2H), 5.40 (d, J = 
4.4 Hz, 1H), 4.74 – 4.71 (1H, m), 3.73 (s, 3H), 3.48 – 3.43 (m, 1H), 3.33 – 3.28 (m, 1H); 
13C NMR (126 MHz, (CD3)2SO): δ 166.3, 158.3, 135.8, 134.5, 131.0, 128.2, 127.2, 
127.1, 113.4, 70.7, 55.0, 47.7; IR (film) 3294, 3053, 2935, 2838, 2011, 1632, 1611,  
1578, 1539, 1509, 1487, 1463, 1443, 1418, 1358, 1316, 1301, 1280, 1240, 1198, 1171, 
1114, 1079, 1030, 1009, 925, 903 cm-1; HRMS calculated for C16H17NO3 [M+Na]+ 
294.1106; observed 294.1100 
________________________________________________________________________ 
5.5 References 
1. Gottfried, F.S. Science 1959, 129, 1466. 
2. Jones, C.G.; Firn, R. D. Philo. T. Roy.Soc. B. 1991, 333, 273. 




	   134	  
4. Challis, G. L.; Hopwood, D. A. Proc. Natl. Acad. Sci. U. S. A. 2003, 100, 14555. 
5. Dyer, L. A.; Richards, L. A.; Short, S. A.; Dodson, C. D. PLoS One 2013, 8, 
e62528. 
6. Sadyandy, R.; Fernandes, R. A.; Kumar, P. ARKIVOC (Gainesville, FL, U.S.), 
2005, 3, 36.  
7. Aguirre, G.; Salgado-Rodriguez, A.; Flores-Lopez, L. Z.; Parra-Hake, M.; 
Somanathan, R. Rev. Soc. Quim. Mex. 2001, 45, 21. 
8. Brown, R. F. C.; Donohue, A. C.; Jackson, W. R.; McCarthy, T. D. Tetrahedron 
1994, 50, 13739. 
9. Brown, R. F. C.; Jackson, W. R.; McCarthy, T. D. Tetrahedron: Asymmetry 1993, 
4, 205. 
10. Yadav, J. S.; Reddy, P. T.; Nanda, S.; Rao, A. B. Tetrahedron: Asymmetry 2002, 
12, 3381. 
11. Kamal, A.; Shaik, A. A.; Sandbhor, M.; Malik, M. S. Tetrahedron: Asymmetry 
2004, 15, 3939. 
12.  Cortez, N. A.; Aguirre, G.; Parra-Hake, M.; Somanathan, R. Tetrahedron: 
Asymmetry 2013, 24, 1297.  
13. Lee, D.-M.; Lee, J.-C.; Jeong, N.; Lee, K.-I. Tetrahedron: Asymmetry 2007, 18, 
2662. 
14. Buchanan, D. J.; Dixon, D. J.; Scott, M. S.; Laine, D. I. Tetrahedron: Asymmetry 
2004, 15, 195. 
15. Farooqui, T. Neurochem. Res. 2007, 32, 1511. 
16. Farooqui, T. Open Access Insect Physiol. 2012, 4, 1. 
	   135	  
 
Chapter 6: Conclusions and Future Direction 
 
6.1. Conclusions and Future Direction 
              In summary, a base mediated heterolysis of N-chloro ureas generated the diaza-
allyl cationic intermediates and reacted in situ with cyclic dienes to provide 1,4-diamines, 
and cyclic ureas, in good to excellent yields. Currently our efforts are focused on 
understanding the mechanism of the cycloaddition reaction with N-chloro ureas. 
Problems with the lack of regioselectivity poor substrate scope issues have been resolved 
by method that uses a direct oxidation of N,N'-dibenzyloxy ureas and PhI(OAc)2, as an 
oxidant. The oxidative diamination reaction is simple to perform and compatible with 
variety of substrates including cyclic, acyclic and heterocyclicaromatics, and provides 
unique heterocyclic products. This oxidative deamination is based up on the reactivity of 
diaza-oxyally cationic intermediate with 4-π reactants and provides the exclusive 
selectivity for the 1,4-diamination. 
 
                 The reactivity of daizoxyallyl cation intermediate has expanded for the 
development of dearomative indole (3+2) cycloaddition reaction of putative transient 
diaza-oxyallyl cationic intermediate for the synthesis of imidazole- indolines using 
simple urea derivative and (diacetoxyiodo)benzene as the stoichiometric oxidant. This 
reaction is compatible with various functional groups and provides a broad substrate 
scope and chemical space. Evaluation of the biological activity of these compounds is 
underway.  
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           We have developed scalable enantioselective synthesis of natural products 
octopamine and aegeline analogues. The natural and unnatural products mixture 
demonstrated the synergistic activity against generalist (Spodoptera) herbivore. One of 
the unnatural analogues found to possess (R-83e analog) inhibitory activity against N-
transferases inhibitor of root growth on a model organism Arabodopsis Thaliana. The 
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Figure A.1.130 13C NMR (126 MHz, (CD3)2SO) spectrum of 78f.	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